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Flammulina velutipes (enoki, velvet shank, golden needle mushroom or winter
mushroom), one of the main edible mushrooms on the market, has long been
recognized for its nutritional value and delicious taste. In recent decades, research has
expanded beyond detailing its nutritional composition and delved into the biological
activities and potential health benefits of its constituents. Many bioactive constituents
from a range of families have been isolated from different parts of the mushroom,
including carbohydrates, protein, lipids, glycoproteins, phenols, and sesquiterpenes.
These compounds have been demonstrated to exhibit various biological activities,
such as antitumour and anticancer activities, anti-atherosclerotic and thrombosis
inhibition activity, antihypertensive and cholesterol lowering effects, anti-aging and
antioxidant properties, ability to aid with restoring memory and overcoming learning
deficits, anti-inflammatory, immunomodulatory, anti-bacterial, ribosome inactivation and
melanosis inhibition. This review aims to consolidate the information concerning the
phytochemistry and biological activities of various compounds isolated from F. velutipes
to demonstrate that this mushroom is not only a great source of nutrients but also
possesses tremendous potential in pharmaceutical drug development.
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INTRODUCTION
In addition to their nutritional value, folk medicine has long recognized mushrooms for
their wide spectrum of therapeutic and prophylactic uses. Many medicinal mushrooms are
important ingredients in Traditional Chinese Medicine, such as Flammulina velutipes (enokitake),
Lentinus edodes (shiitake), and Grifola frondosa (maitake) (Sullivan et al., 2006). While
their properties remained unknown to the scientific community for a long time, in recent
decades, there has been significant research focused on the sources, medicinal properties
and applications of mushrooms (Encarnacion et al., 2012; Kalacˇ, 2013; Soares et al., 2013).
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From a nutritional stand point, these health promoting
mushrooms have high nutritional value. They contain dietary
fiber, are low in calories, have a high content of protein consisting
of all the essential amino acids, minerals and vitamins and
are free of cholesterol (Karaman et al., 2010). Beyond their
nutritional value, mushrooms have great potential for production
of useful metabolites, making them a prolific resource for drug
isolation and development (Leung et al., 1997). Mushrooms
are now gaining worldwide recognition as a functional food
as well as a potential source of nutraceuticals which may
reduce severity of, prevent or treat illnesses. The current
research on these medicinal mushrooms has, in fact, now
progressed beyond validating their traditional medical uses
and into the isolation and production of bioactive compounds
against specific illnesses (Wang et al., 2012c; Liu et al.,
2014).
F. velutipes is also commonly known as enokitake, velvet
shank or golden needle mushroom winter mushroom. The
synonyms for F. velutipes are Agaricus nigripes, Agaricus velutipes,
Collybia eriocephala, Collybia veluticeps, Collybia velutipes,
Collybidium velutipes, Gymnopus velutipes, Myxocollybia
velutipes, Panaeolus veluticeps, Paxillus veluticeps, Phylloporus
veluticeps, and Pleurotus velutipes (Information was retrieved
from MycoBank website http://www.mycobank.org, 1st August
2016). The cultivated F. velutipes has a pure white bean
sprout look with a velvety stem topped with a tiny snowy-
white cap; while the wild varieties appear in different colors
ranging from orange to brown, and have a larger, shiny cap.
The significant difference in the appearance of wild and
the cultivated F. velutipes is attributed to the cultivation of
F. velutipes without the exposure to light which leads to
its white color while the wild ones are brown. F. velutipes
normally grows on dead elm trees and has been found
abundantly on diseased elm trees caused by Dutch elm infection
(Ingold, 1980). The species of Flammulina have also been
reported to occur ubiquitously on a wide variety of deciduous
trees such as poplar, plum, maple and birch (Sharma et al.,
2009).
F. velutipes (Curtis) Singer is one of the most popular
edible mushrooms that possesses a wide spectrum of interesting
biological activities. It is found ubiquitously throughout the
north-temperate regions including North America, Europe and
Asia (Ingold, 1980). Historically, it has been has been cultivated
for consumption and medicinal use in China since 800 AD.
Currently, F. velutipes is among the four most widely cultivated
mushrooms globally due to its desirable taste, aroma and high
nutritional value. It is commonly available in the market or
groceries stores sold in vacuum packages. This mushroom is
also well known for its curative properties for liver diseases and
gastroenteric ulcers (Ingold, 1980).
Research on F. velutipes has clearly shown it possesses various
pharmacological properties including anticancer, antimicrobial,
antioxidant, and immunomodulatory properties, demonstrating
that F. velutipes has great potential for successful bioprospecting.
We aim to give an overview of the present knowledge regarding
the bioactive chemical constituents and pharmacological
potential of F. velutipes.
TAXONOMIC CLASSIFICATION OF
F. VELUTIPES
Taxonomic level Taxonomic name
Kingdom Fungi
Phylum Basidiomycota
Class Agaricomycetes
Order Agaricales
Family Physalacriaceae
Genus Flammulina
Species F. velutipes
CHEMICAL COMPOSITION AND
NUTRITIONAL VALUE OF F. VELUTIPES
Similar to many other edible mushrooms, F. velutipes is
consumed as a delicacy, noted for the pleasant aroma and texture
it gives to a dish. More importantly, consuming F. velutipes
can provide key nutrients such as proteins, vitamins, minerals,
unsaturated fatty acids and fiber. Additionally, consumption
of F. velutipes can confer health promoting effects including
immunity enhancement, blood cholesterol and blood pressure
lowering effects as well as chemopreventive effects by virtue of
the bioactive constituents contained in the mushroom which
are ingested during consumption. However, it is important to
note that the composition of the beneficial compounds present
in F. velutipes can be highly influenced by the growing site,
types of substrate, maturity of the mushroom at the harvesting
stage and also the post-harvest handling including the processing
and storage conditions. All these factors could account for the
variability in composition data published by different studies
examining the same mushroom, in addition to the intraspecific
genetic variability of mushrooms from different provenance and
producers (Reis et al., 2012). We have consolidated the data
available in the current literature reporting the nutrient analysis
of F. velutipes collected from several regions in order to provide
further insight into the nutritional benefits of consuming this
mushroom.
Based on the findings of Kalacˇ (2013), the dry matter of both
wild and cultivated mushrooms is relatively low, usually within
the range of 80–140 g/kg. For F. velutipes, the dry matter of both
wild and cultivated F. velutipes are within the normally reported
range for mushrooms, measuring between 93 and 114 g/kg
(Dikeman et al., 2005; Ko et al., 2007; Beluhan and Ranogajec,
2011; Reis et al., 2012). The low dry matter of the mushrooms
accounts for their high water content that leads to shorter shelf
life of the fruiting bodies. However, in a comparison among
cultivated mushrooms, Dikeman et al. (2005) found that the dry
matter of cultivated raw F. velutipes was the highest among the
other cultivatedmushrooms sampled for the study. However, this
was not the case for the studies that examined the wild F. velutipes
collected from European regions (Beluhan and Ranogajec, 2011;
Pereira et al., 2012). Furthermore, the dry matter content of F.
velutipes was reduced after cooking while the dry matter of the
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TABLE 1 | The proximate composition of F. velutipes in dry weight basis.
Proximate composition
(g/kg dry matter)
Origin of growing site References
Wild Cultivated
Dry matter 93.2–119.5 103.0–114.0 Dikeman et al., 2005; Ko et al., 2007; Beluhan and Ranogajec, 2011; Pereira et al., 2012; Reis
et al., 2012
Carbohydrates 426.0–708.5 580.0–871.4 Ko et al., 2007; Beluhan and Ranogajec, 2011; Akata et al., 2012; Pereira et al., 2012; Reis
et al., 2012
Proteins 232.0–275.0 178.9–279.5 Dikeman et al., 2005; Ko et al., 2007; Beluhan and Ranogajec, 2011; Akata et al., 2012;
Pereira et al., 2012
Fats 17.3–70.0 18.4–73.3 Dikeman et al., 2005; Ko et al., 2007; Beluhan and Ranogajec, 2011; Akata et al., 2012;
Pereira et al., 2012; Reis et al., 2012
Ash 72.5–74.0 73.9–104.0 Ko et al., 2007; Beluhan and Ranogajec, 2011; Akata et al., 2012; Pereira et al., 2012; Reis
et al., 2012
Energy (kcal/kg fresh
weight)
342.0–398.2 410.1–459.3 Ko et al., 2007; Beluhan and Ranogajec, 2011; Pereira et al., 2012; Reis et al., 2012
*Energy (kcal) = 4 × (g carbohydrate) + 3.75 × (g protein) + 9 × (g fat) (Reis et al., 2012).
other mushrooms was increased after cooking, suggesting that
cooking can result in losses for F. velutipes.
The data on approximate composition and energy value of
both wild and cultivated F. velutipes are summarized in Table 1.
All the studies reviewed showed that carbohydrates and proteins
are the two major constituents contained in the dry matter of
F. velutipes. No obvious difference is seen in carbohydrate and
protein content between the wild and cultivated F. velutipes.
Given the fact that, similar to other mushrooms, F. velutipes
has low dry matter and fats content, it is thus a low energy
delicacy. Furthermore, the calculated energy value is suggested to
be somewhat overestimated as some of the carbohydrates are only
partially digestible or indigestible, such as chitin and mannitol
(Kalacˇ, 2013). It is interesting to note that a slight difference can
be observed between the energy value of wild and the cultivated F.
velutipes, where the energy value of cultivated F. velutipes appears
higher than the wild F. velutipes, ranging from 410.1 to 459.3
kcal/kg fresh weight and from 342.0 to 398.2 kcal/kg fresh weight,
respectively. The energy value was computed according to the
following equation: Energy (kcal)= 4× (g carbohydrate)+ 3.75
× (g protein)+ 9× (g fat) (Reis et al., 2012).
Protein and Amino Acids
Protein represents the most critical component contributing to
the nutritional value of a particular food, due to the fact that fats
and carbohydrates are rarely lacking in a diet. As one of the major
components in the dry matter of F. velutipes, protein accounts for
approximately 178.9 g/kg dry weight to 279.5 g/kg dry weight of
F. velutipes (Dikeman et al., 2005; Ko et al., 2007; Beluhan and
Ranogajec, 2011; Akata et al., 2012; Pereira et al., 2012). The large
range in the protein concentrations could be explained by the fact
that protein concentration in this mushroom been shown to vary
depending on the growth substrate, size of pileus, time of harvest
and the availability of nitrogen sources in the growth substrate.
The protein content of F. velutipes is comparable to many green
leafy vegetables— in the range of 200–300 g/kg dry weight (Singh
et al., 2001; Gupta et al., 2005)—demonstrating that F. velutipes is
a good source of protein. Several unique studies even quantified
the concentration of amino acids from F. velutipes. Amino acids
are the important monomeric building blocks of proteins and can
further classified into two classes, the essential and nonessential
amino acids. The essential amino acids can only be obtained
through dietary intake while the non-essential amino acids are
those that can be synthesized by the body. Varying concentrations
of free amino acids contained in F. velutipes were demonstrated
in the studies reviewed (Table 2) (Smiderle et al., 2008; Kim et al.,
2009; Beluhan and Ranogajec, 2011). Based on these studies,
the major amino acids found in F. velutipes were L-glutamic
acid, L-alanine, glycine and L-lysine, which contributed 2.6–
3.0% of dry weight. Furthermore, essential amino acids such as
methionine, valine, isoleucine, leucine, lysine, phenylalanine and
threonine were detected in F. velutipes (Smiderle et al., 2008; Kim
et al., 2009; Beluhan and Ranogajec, 2011). Amino acids also
play an important role in contributing to the pleasant taste of
mushrooms. For instance, aspartic and glutamic acids are the two
amino acids that contribute the monosodium glutamate-like or
palatable taste while the alanine, glycine, threonine and serine
give a sweet taste to the mushrooms. Beluhan and Ranogajec
(2011) found that among the amino acids in F. velutipes, amino
acids that give MSG-like taste made up the highest composition,
followed by sweet, bitter and tasteless amino acids. The study also
showed that among a variety of mushrooms, the total content
of amino acids that determined the taste characteristics of F.
velutipes was the lowest at 27.87 mg/g dry weight, accounting
for the delicate and very mild in taste of F. velutipes unlike other
mushroom species which have stronger flavor and taste (Beluhan
and Ranogajec, 2011).
Besides that, various bioactive proteins also have been
isolated from F. velutipes. Fungal immunomodulatory protein,
FIP-fve, mainly extracted from fruiting body of F. velutipes
has been studied extensively and explored for its diverse
bioactivities including immunomodulatory, anticancer and anti-
inflammatory properties (Chang et al., 2013, 2014; Lee et al.,
2013). Ribosome inactivating proteins such as flammin, velin,
velutin and flammulin are present in the fruiting bodies and
extract of the mushroom (Wang and Ng, 2000, 2001; Ng and
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TABLE 2 | Concentration of amino acids of F. velutipes.
Amino acids (mg/g dry weight) Source of F. velutipes
Local supermarket, Korea
(Kim et al., 2009)
Municipal market, Brazil
(Smiderle et al., 2008)
Forests, Croatia regions (Beluhan
and Ranogajec, 2011)
D,L-O-Phosphoserine 1.31 nt nt
Taurine 1.74 nt nt
L-Aspartic acid 2.81 nt 2.59
L-Threonine 6.41 10.047 5.21
L-Serine 6.83 7.686 0.21
L-Glutamic Acid 31.54 9.975 29.98
D,L-α-Aminoadipic Acid 0.64 nt nt
Glycine 6.13 28.482 0.15
L-Alanine 26.86 7.591 1.95
L-Valine 1.76 6.539 1.54
L-Cysteine 6.32 8.76 1.39
L-Methionine 0.06 3.108 0.03
L-Cystathionine 1.89 nt nt
L-Isoleucine 0.37 5.09 0.44
L-Tyrosine 0.99 3.471 0.04
L-Phenylalanine 0.19 5.654 1.23
D,L-β-Amino-i-Butyric Acid 2.16 nt nt
γ-AminoButyric Acid 11.63 nt nt
Ethanolamine 1.68 nt nt
D,L & allo-Hydroxylysine 0.3 nt nt
L-Ornithine 12.55 nt nt
L-Lysine 6.21 30.896 5.68
L-Histidine 2.44 1.456 2.54
L-Carnosine 0.56 nt nt
L-Arginine 1.27 3.88 0.49
L-Leucine 0.49 5.404 0.73
Proline nt 4.947 nt
nt, not tested.
Wang, 2004). Studies have also reported isolation of proteins
such as hemagglutanin which has mitogenic and antiproliferative
functions, ice binding proteins and also the flammutoxin as a
cytolysin (Tadjibaeva et al., 2000; Ng et al., 2006; Raymond and
Janech, 2009). In addition, proflamin, a glycoprotein enzyme
with anticancer activity, and asparaginase were also discovered in
the mycelium of the mushroom (Maruyama and Ikekawa, 2007;
Eisele et al., 2011; Kotake et al., 2011).
Carbohydrates
Based on the available data, carbohydrates generally constitute
roughly one-half of the total dry weight of F. velutipes. Cultivated
F. velutipes have a slightly higher median value of carbohydrate
content compared to the wild F. velutipes (Ko et al., 2007;
Beluhan and Ranogajec, 2011; Akata et al., 2012; Pereira et al.,
2012; Reis et al., 2012). Carbohydrates in F. velutipes can be
categorized into three main groups: monosaccharides such as
ribose, mannose, glucose, xylose, fucose, galactose, and fructose;
disaccharides such as sucrose and trehalose, and polysaccharides
such as chitin, β-glucan and starch (Dikeman et al., 2005;
Kim et al., 2009; Beluhan and Ranogajec, 2011; Pereira et al.,
2012; Reis et al., 2012). The concentration of each individual
group of carbohydrates contained in F. velutipes is tabulated in
Table 3. The observed differences in sugar content may be due
to geographical factors such as soil conditions, as well as the
cultivation method and also the analytical method used. Glucose
and trehalose were the two major sugar components detected
in both wild and cultivated F. velutipes (Dikeman et al., 2005;
Kim et al., 2009; Beluhan and Ranogajec, 2011; Pereira et al.,
2012; Reis et al., 2012). It was indicated that sugars participate
in cellular energy metabolism and also the synthesis of structural
polysaccharides of the mushroom (Barros et al., 2008). Moreover,
sugars are only a small portion of the total carbohydrate content
while the remaining portion consists of other polysaccharides
such as starch, chitin and β-glucan.
Recently, there have been increased investigations into
the bioactivities of polysaccharides extracted from both the
fruiting body and mycelium of F. velutipes. F. velutipes
derived polysaccharides were found to possess many health
promoting properties, such as antioxidant and anticancer
activity, immunomodulation, hepatocyte protection and even the
ability to treat learning and memory impairment (Pang et al.,
2007; He and Zhang, 2013; Wu et al., 2014; Yang et al., 2015)
(Zhang et al., 2013). Beta-glucan is one of the many interesting
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TABLE 3 | Concentration of monosaccharides, disaccharides and polysaccharides of F. velutipes.
Carbohydrates (mg/g dry weight) Provenance References
Wild Cultivated
Monosaccharides Fucose nt 12 Dikeman et al., 2005
Mannose 72.3 7.51–61 Dikeman et al., 2005; Kim et al.,
2009; Beluhan and Ranogajec, 2011
Glucose 120.1 11.34–575 Dikeman et al., 2005; Kim et al.,
2009; Beluhan and Ranogajec, 2011
Ribose nt 11.47 Kim et al., 2009
Xylose nt 28–51.56 Dikeman et al., 2005; Kim et al., 2009
Fructose nd 379.23 Kim et al., 2009; Reis et al., 2012
Mannitol 59.8–79.0 79.97 Beluhan and Ranogajec, 2011;
Pereira et al., 2012; Reis et al., 2012
Galactose nt 27 Dikeman et al., 2005
Disaccharides Trehalose 29.7–150.8 2.33–216.82 Kim et al., 2009; Beluhan and
Ranogajec, 2011; Pereira et al., 2012;
Reis et al., 2012
Sucrose nt nd, 7.41 Kim et al., 2009; Reis et al., 2012
Polysaccharides Chitin nt 97 Dikeman et al., 2005
β-glucan nt 2 Dikeman et al., 2005
Starch nt 150 Dikeman et al., 2005
nd, not detected; nt, not tested.
polysaccharides found in F. velutipes, having demonstrated
anticancer properties (Smiderle et al., 2006).
Carbohydrate content also includes dietary fiber, which is
known to be high in mushrooms. According to Kalacˇ (2013),
both insoluble and soluble dietary fiber content were shown to
make up between 4.2–9.2% and 22.4–31.2% of dry weight in
mushrooms. Dikeman et al. (2005) revealed that approximately
29.3% of the dry weight of raw F. velutipes consists of dietary
fibers; with 90% of the total dietary fiber being insoluble while
the remaining 10% is soluble. Furthermore, it was found that
the total dietary fiber content increased as a result of cooking
for F. velutipes (Dikeman et al., 2005). A previous study also
demonstrated that the high dietary fiber content of F. velutipes
extract conferred hypolipidemic effect, lowering total cholesterol
levels in animals on a high fat diet (Yeh et al., 2014).
Lipids and Fatty Acids
Generally, mushrooms are a low energy delicacy with a caloric
value of approximately 350 kcal per kg owing to its low dry
matter and lipid content (Kalacˇ, 2013). The lipid content of F.
velutipes falls in the range of 17.3–73.3 g/kg dry weight and
is composed of sterols, sphingolipids and fats (Ko et al., 2007;
Beluhan and Ranogajec, 2011; Akata et al., 2012; Pereira et al.,
2012). The total fatty acid content (in terms of dry weight
basis) of F. velutipes consists predominantly of monounsaturated
and polyunsaturated fatty acids (79.23%) while saturated fatty
acids make up the remaining 20.67% (Günç Ergönül et al.,
2013). Table 4 summarizes the percentages of the individual fatty
acids detected in F. velutipes. Linoleic acid is the major fatty
acid contained in F. velutipes, making up 40.93–56.33% of the
TABLE 4 | Main fatty acids (percentage) found in F. velutipes.
Main fatty Percentage (%) References
acids
Stearic acid 1.38–3.56 Pereira et al., 2012; Günç Ergönül et al., 2013
Palmitic acid 10.31–14.56 Pereira et al., 2012; Günç Ergönül et al., 2013
Oleic acid 15.08–16.43 Pereira et al., 2012; Günç Ergönül et al., 2013
Linoleic acid 40.93–56.33 Pereira et al., 2012; Günç Ergönül et al., 2013
total fatty acid content. Linoleic acid is an essential fatty acid
for mammals and is the precursor for biosynthesis of many
important inflammatory mediators such as arachidonic acid and
prostaglandins inmammals (Salem et al., 1999). Thus, F. velutipes
may represent an important food source for humans or other
animals to obtain sufficient amounts of the essential fatty acids
our body requires but which cannot be synthesized. Many studies
also demonstrated that sterols extracted from F. velutipes possess
antiproliferative activity against several cancer cell lines and have
the potential to be developed as chemotherapeutic agents (Yi
et al., 2012, 2013a); while mycosterol, derived from the extract
of F. velutipes, exhibits potent hypolipidemic activity (Yeh et al.,
2014).
Micronutrients
The ash content in mushrooms generally ranges within 5–12%
of dry matter and 72.5–104.0 g/kg of ash was reported in F.
velutipes (Ko et al., 2007; Beluhan and Ranogajec, 2011; Akata
et al., 2012; Pereira et al., 2012). The concentration of elements
contained in F. velutipes are tabulated in Table 5. Similar to
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TABLE 5 | Content of major mineral elements in F. velutipes.
Minerals Concentration
(mg/g dry weight)
References
Calcium 0.36–1.18 Smiderle et al., 2008; Zeng et al., 2012
Potassium 28.00–28.98 Smiderle et al., 2008; Zeng et al., 2012
Sodium 0.657–0.755 Smiderle et al., 2008; Zeng et al., 2012
Magnesium 0.68–1.43 Smiderle et al., 2008; Zeng et al., 2012
Zinc 0.048–0.068 Smiderle et al., 2008; Zeng et al., 2012
Selenium <0.00050 Smiderle et al., 2008
Lithium <0.00020 Smiderle et al., 2008
Copper 0.057 Zeng et al., 2012
Manganese 0.0096 Smiderle et al., 2008
Iron 0.0963 Smiderle et al., 2008
Sulfur 6.06 Zeng et al., 2012
Phosphorus 8.80–9.40 Smiderle et al., 2008
other mushrooms (Manzi et al., 1999; Smiderle et al., 2008; Zeng
et al., 2012), potassium is the most abundant mineral element
contained in F. velutipes (28.00–28.98mg/g dry weight), followed
by phosphorus (8.80–9.40 mg/g dry weight). This indicates
that a 100g portion of F. velutipes can contribute to around
9% of the recommended daily intake of potassium which is
3100 mg/day according to FDA (Akhter et al., 2003). The high
potassium and low sodium content may also make F. velutipes
of potential benefit in a salt restricted diet for suitable for
those with hypertension or heart disease. In fact, studies also
suggested that potassium from fruit and vegetables can reduce
blood pressure (John et al., 2002; He et al., 2006). The other
minerals present inminor amounts include copper, iron, zinc and
sulfur, which are also important supplementary elements in our
diet (Smiderle et al., 2008). It is also interesting to note that the
wild Australian F. velutipes contain higher copper and potassium
levels as compared to other Australian mushrooms species (Zeng
et al., 2012).
It has been demonstrated that the vitamin content in
mushrooms are species and source-dependent (Pereira et al.,
2012; Nakalembe et al., 2015). According to Pereira et al. (2012),
F. velutipes was shown to contain tocopherols (α-tocopherol, β-
tocopherol and δ-tocopherol, but not γ-tocopherol) (0.6 µg/g
dry weight), ascorbic acid (238 µg/g dry weight), β-carotene
(3.4 µg/g dry weight) and lycopene (0.2 µg/g dry weight).
These vitamins or micronutrients may play an important role
in contributing to the mushroom’s antioxidant activity (Breene,
1990; Pereira et al., 2012).
Health Promoting
Constituents/Non-nutrients
Besides the macronutrients and micronutrients present in F.
velutipes, phenolics, especially the phenolic acids which are
known to be the main antioxidants in the mushroom, have
been detected (Kim et al., 2008; Rahman et al., 2015). Phenolics
are heterocyclic compounds and well-recognized for their
potent antioxidant activity; they are particularly effective in
protecting the body against diseases associated with oxidative
stresses such as cancer, cardiovascular disease and diabetes.
Rahman et al. (2015) identified several polyphenolic antioxidants
present in the methanol:dichloromethane fraction of F. velutipes,
including the protocatechuic acid (1), p-coumaric (2), and
ellagic acid (3). These bioactive phenolic and polyphenolic
compounds confer the antioxidative effect of F. velutipes in
preventing the progression of atherosclerosis (Rahman et al.,
2015). Gallic acid (4), pyrogallol (5), homogentisic acid (6),
5-sulfosalicylic acid (7), chlorogenic acid (8), caffeic acid (9),
ferulic acid (10), and quercetin (11) are other examples of
phenolic compounds detected in F. velutipes, ranging from
9.0 to 26.0 µg/g dry weight (Kim et al., 2008). The chemical
structures of these bioactive compounds are illustrated in
Figure 1. Interestingly, an interspecies comparison study by Zeng
et al. (2012) showed that F. velutipes had the highest phenolic
content of 2.823 ± 0.007mg gallic acid equivalent (GAE)/g
extract among other mushrooms harvested from Australia. The
study also suggested the variation in the phenolic content in
those mushrooms may be ascribed to the different geographical
locations and also dependent on the ability of a particular sub-
species in the synthesis of phenolic compounds (Zeng et al.,
2012).
In addition, various novel sesquiterpenes and
norsequiterpenes were also identified from the extract of F.
velutipes. These compounds exhibited several bioactivities such
as anticancer, antibacterial and antioxidant activity (Wang
et al., 2012a,d). Lovastatin, (12) which is effective in lowering
cholesterol levels, was detected in the fruiting bodies of F.
velutipes, estimated at 90.8 ± 2.0mg/kg dry weight (Chen et al.,
2012).
In summary, F. velutipes has excellent nutritional content—
high protein and carbohydrate content, low fat content and also
high polyunsaturated fatty acid content, making it an excellent
food suitable for low calorie diet. However, as noted, there are
differences in the chemical composition between the cultivated
and the wild samples of F. velutipes, including carbohydrates,
proteins and fatty acid profiles. Based on the current literature,
it should be noted that data on digestibility and bioavailability of
F. velutipes or indeed any other mushrooms are still lacking. In
future, more studies could explore the bioavailability of specific
nutrients or bioactive constituents contained in F. velutipes as
well as investigate the changes in the individual constituents
during different preservation methods, storage conditions and
different cooking processes.
BIOLOGICAL ACTIVITIES OF F. VELUTIPES
F. velutipes has been reported to have multiple beneficial effects
on human health. They include antitumour, anticancer and anti-
atherosclerotic activity, thrombosis inhibition, antihypertensive
and cholesterol lowering effects, anti-aging and antioxidant
properties, ability to restore neurotransmitters associated with
memory and learning, anti-inflammatory, immunomodulatory
and anti-bacterial activities (Gu and Leonard, 2006; Karaman
et al., 2010; Lee et al., 2013; Wu et al., 2014; Rahman et al., 2015;
Yang et al., 2015). These biological activities of F. velutipes are
summarized in Table 6; a summary of the biological activities of
F. velutipes in a graphical from is depicted in Figure 2.
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FIGURE 1 | The chemical structures of bioactive constituents isolated from F. velutipes.
Antitumor and Anticancer
With the increasing rate of life-threatening neoplastic diseases in
recent years, development of more effective antitumor drugs is a
research area of great relevance (Ajith and Janardhanan, 2007).
Currently, chemotherapeutic agents used in cancer treatment are
able to slow down the progress of the disease; however, they are
also toxic toward healthy, non-neoplastic cells (Tan et al., 2016b).
An alternative approach currently being explored intensively
is pursuing anticancer agents from natural food products to
inhibit the onset of cancer (Chung et al., 2010; Chan et al., 2012;
Goh et al., 2014; Tan et al., 2016a). Over the years, bioactive
compounds derived from Inonotus obliquus (chaga mushroom)
and L. edodes (shiitake) have been shown to exhibit anticancer
effects against certain cell lines such as human leukemic U937
cells, stomach adenocarcinoma AGS cells, lung carcinoma A549
cells, sarcoma S-180 cells and human colorectal adenocarcinoma
Frontiers in Pharmacology | www.frontiersin.org 7 December 2016 | Volume 7 | Article 474
Tang et al. Flammulina velutipes
T
A
B
L
E
6
|
T
h
e
b
io
a
c
ti
v
it
ie
s
o
f
e
x
tr
a
c
ts
a
n
d
c
o
n
s
ti
tu
e
n
ts
is
o
la
te
d
fr
o
m
F
.
v
e
lu
ti
p
e
s
.
B
io
a
c
ti
v
it
ie
s
Te
s
te
d
s
u
b
s
ta
n
c
e
E
x
p
e
ri
m
e
n
ta
l
d
e
s
ig
n
D
o
s
a
g
e
a
n
d
re
s
u
lt
s
R
e
fe
re
n
c
e
s
A
n
tit
u
m
o
r
a
n
d
a
n
tic
a
n
c
e
r
W
a
te
r
e
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
In
vi
tr
o
c
e
ll
c
u
ltu
re
,
B
T-
2
0
,
M
C
F
-7
a
n
d
M
D
A
-M
B
-2
3
1
c
e
lls
G
ro
w
th
in
h
ib
iti
o
n
a
g
a
in
st
B
T-
2
0
,
M
C
F
-7
a
n
d
M
D
A
-M
B
-2
3
1
a
t
IC
5
0
=
3
0
,
1
5
0
,
a
n
d
7
5
µ
g
/m
L
,
re
sp
e
c
tiv
e
ly
G
u
a
n
d
L
e
o
n
a
rd
,
2
0
0
6
F
la
m
m
u
lin
o
lid
e
A
(1
5
)
F
la
m
m
u
lin
o
lid
e
B
(1
6
)
F
la
m
m
u
lin
o
lid
e
C
(1
7
)
F
la
m
m
u
lin
o
lid
e
F
(2
0
)
In
vi
tr
o
c
e
ll
c
u
ltu
re
,
H
e
la
,
H
e
p
G
2
a
n
d
K
B
c
e
lls
F
la
m
m
u
lin
o
lid
e
A
(1
5
),
B
(1
6
)
a
n
d
F
(2
0
)—
c
yt
o
to
xi
c
ity
a
g
a
in
st
K
B
c
e
ll
a
t
IC
5
0
=
3
.9
,
3
.6
a
n
d
4
.7
µ
M
F
la
m
m
u
lin
o
lid
e
C
(1
7
)—
c
yt
o
to
xi
c
ity
a
g
a
in
st
H
e
la
a
t
IC
5
0
=
3
.0
µ
M
W
a
n
g
e
t
a
l.,
2
0
1
2
c
E
n
o
ki
p
o
d
in
B
(2
2
)
E
n
o
ki
p
o
d
in
D
(2
3
)
E
n
o
ki
p
o
d
in
J
(3
0
)
2
,5
-c
u
p
a
ra
d
ie
n
e
-1
,4
-d
io
n
e
(2
4
)
In
vi
tr
o
c
e
ll
c
u
ltu
re
,
H
e
p
G
2
,
M
C
F
-7
,
A
5
4
9
a
n
d
S
G
C
7
9
0
1
c
e
lls
M
o
d
e
ra
te
c
yt
o
to
xi
c
ity
a
g
a
in
st
a
ll
th
e
te
st
e
d
c
a
n
c
e
r
c
e
ll
lin
e
s
w
ith
IC
5
0
w
ith
in
2
0
to
1
0
0
µ
g
/m
L
W
a
n
g
e
t
a
l.,
2
0
1
2
d
A
n
o
ve
ln
o
rs
e
q
u
ite
rp
e
n
e
a
lk
a
lo
id
(3
1
)
In
vi
tr
o
c
e
ll
c
u
ltu
re
,
K
B
c
e
ll
C
yt
o
to
xi
c
ity
a
g
a
in
st
K
B
c
e
lls
a
t
IC
5
0
=
1
6
.6
µ
M
X
u
e
t
a
l.,
2
0
1
3
A
lk
a
lin
e
-s
o
lu
b
le
p
o
ly
sa
c
c
h
a
rid
e
fr
o
m
c
e
ll
w
a
ll
o
f
F.
ve
lu
ti
p
e
s
S
C
-1
8
0
m
o
u
se
m
o
d
e
l
S
ig
n
ifi
c
a
n
t
in
h
ib
iti
o
n
(9
4
.1
–9
7
.8
%
)
o
n
th
e
g
ro
w
in
g
o
f
S
C
-1
8
0
tu
m
o
r
a
t
d
o
se
o
f
1
5
m
g
/k
g
L
e
u
n
g
e
t
a
l.,
1
9
9
7
H
o
t-
w
a
te
r
e
xt
ra
c
t
o
f
p
o
ly
sa
c
c
h
a
rid
e
s
fr
o
m
F.
ve
lu
ti
p
e
s
fr
u
iti
n
g
b
o
d
y
S
-1
8
0
m
ic
e
tu
m
o
r
m
o
d
e
la
n
d
S
M
M
C
-7
7
2
1
h
u
m
a
n
h
e
p
a
to
m
a
c
e
lls
(in
vi
tr
o
)
In
h
ib
iti
o
n
(5
4
.7
–5
8
.1
%
)
o
n
p
ro
lif
e
ra
tio
n
o
f
S
-1
8
0
im
p
la
n
te
d
tu
m
o
r
in
vi
vo
a
t
d
o
se
o
f
2
4
m
g
/k
g
5
9
.5
%
in
h
ib
iti
o
n
o
n
p
ro
lif
e
ra
tio
n
o
f
S
M
M
C
-7
7
2
1
c
e
lls
a
t
5
0
m
g
/F
.
ve
lu
ti
p
e
s
p
o
ly
sa
c
c
h
a
rid
e
in
vi
tr
o
Ji
a
n
g
e
t
a
l.,
1
9
9
9
P
o
ly
sa
c
c
h
a
rid
e
e
xt
ra
c
ts
fr
o
m
F.
ve
lu
ti
p
e
s
m
yc
e
liu
m
In
vi
tr
o
c
e
ll
c
u
ltu
re
,
B
E
L
-7
4
0
2
c
e
ll
F
vP
-2
a
n
d
F
vP
3
sh
o
w
e
d
in
h
ib
iti
o
n
a
g
a
in
st
B
E
L
-7
4
0
2
fo
r
4
5
%
a
n
d
4
0
%
a
t
2
0
µ
g
/m
L
a
n
d
4
0
µ
g
/m
L
,
re
sp
e
c
tiv
e
ly
Z
h
a
o
e
t
a
l.,
2
0
1
3
Tr
ip
le
h
e
lic
a
lp
o
ly
sa
c
c
h
a
rid
e
In
vi
tr
o
c
e
ll
c
u
ltu
re
,
B
C
G
-8
2
3
a
n
d
A
5
4
9
F
V
P
-1
sh
o
w
e
d
in
h
ib
ito
ry
ra
te
o
f
3
2
.3
%
a
g
a
in
st
A
5
4
9
a
t
1
0
0
µ
g
/m
L
;
7
8
%
a
g
a
in
st
B
G
C
-8
2
3
a
t
2
0
0
µ
g
/m
L
F
V
P
-2
sh
o
w
e
d
in
h
ib
ito
ry
ra
te
o
f
2
7
.9
%
a
g
a
in
st
A
5
4
9
a
t
2
0
0
µ
g
/m
L
;
9
5
%
a
g
a
in
st
B
G
C
-8
2
3
a
t
2
0
0
µ
g
/m
L
Y
a
n
g
e
t
a
l.,
2
0
1
2
S
te
ro
ls
(e
rg
o
st
e
ro
l(
3
2
)
(5
4
.8
%
)
a
n
d
2
2
,
2
3
-d
ih
yd
ro
e
rg
o
st
e
ro
l(
3
3
)
(2
7
.9
%
))
e
xt
ra
c
te
d
fr
o
m
F.
ve
lu
ti
p
e
s
In
vi
tr
o
c
e
ll
c
u
ltu
re
,
S
G
C
,
H
e
p
G
2
,
A
5
4
9
a
n
d
U
2
5
1
C
yt
o
to
xi
c
ity
a
g
a
in
st
S
G
C
c
e
ll
w
ith
IC
5
0
a
t
1
1
.9
9
µ
g
/m
L
;
H
e
p
G
-2
c
e
ll
w
ith
IC
5
0
a
t
9
.3
µ
g
/m
L
;
A
5
4
9
lu
n
g
c
a
n
c
e
r
c
e
ll
w
ith
IC
5
0
a
t
2
0
.4
µ
g
/m
L
a
n
d
U
2
5
1
g
lio
b
la
st
o
m
a
w
ith
IC
5
0
a
t
2
3
.4
2
µ
g
/m
L
Y
ie
t
a
l.,
2
0
1
2
,
2
0
1
3
a
,b
F
IP
-f
ve
,
a
n
im
m
u
n
o
m
o
d
u
la
to
ry
p
ro
te
in
In
vi
tr
o
c
e
ll
c
u
ltu
re
,
A
5
4
9
c
e
ll
B
N
L
h
e
p
a
to
m
a
-b
e
a
rin
g
fe
m
a
le
B
A
L
B
/c
m
ic
e
R
e
d
u
c
e
d
e
xp
re
ss
io
n
o
f
R
A
C
G
A
P
1
g
e
n
e
re
sp
o
n
si
b
le
fo
r
m
e
ta
st
a
si
s
R
e
d
u
c
e
d
tu
m
o
r
si
ze
o
f
B
N
L
h
e
p
a
to
m
a
in
m
ic
e
(1
0
m
g
/k
g
o
ra
la
d
m
in
is
tr
a
tio
n
)
b
y
e
xp
re
ss
io
n
o
f
IF
N
-γ
th
ro
u
g
h
E
R
K
/M
A
P
K
si
g
n
a
lin
g
p
a
th
w
a
y;
in
h
ib
ite
d
a
n
g
io
g
e
n
e
si
s
th
ro
u
g
h
C
D
4
+
T-
c
e
ll-
d
e
riv
e
d
IF
N
-γ
In
h
ib
ite
d
th
e
p
ro
lif
e
ra
tio
n
o
f
A
5
4
9
m
e
d
ia
te
d
th
ro
u
g
h
th
e
in
c
re
a
se
d
p
5
3
a
n
d
p
2
1
e
xp
re
ss
io
n
A
c
te
d
a
s
a
d
ju
va
n
t
w
ith
H
P
V
-1
6
E
7
,
in
c
re
a
se
d
lif
e
sp
a
n
o
f
tu
m
o
r-
b
e
a
rin
g
m
ic
e
th
ro
u
g
h
in
c
re
a
se
d
H
P
V
-1
6
E
7
-s
p
e
c
ifi
c
a
n
tib
o
d
ie
s
a
n
d
T
c
e
lls
C
h
a
n
g
e
t
a
l.,
2
0
1
0
,
2
0
1
3
P
ro
fla
m
in
,
a
g
ly
c
o
p
ro
te
in
e
xt
ra
c
te
d
fr
o
m
m
yc
e
liu
m
o
f
F.
ve
lu
ti
p
e
s
Tu
m
o
r
b
e
a
rin
g
m
ic
e
m
o
d
e
lw
ith
B
-1
6
m
e
la
n
o
m
a
a
n
d
C
a
7
5
5
a
d
e
n
o
c
a
rc
in
o
m
a
In
c
re
a
se
d
m
e
a
n
su
rv
iv
a
lt
im
e
o
f
m
ic
e
w
ith
B
-1
6
a
n
d
C
a
-7
5
5
fo
r
8
6
a
n
d
8
4
%
,
re
sp
e
c
tiv
e
ly
,
a
t
1
0
m
g
/k
g
a
d
m
in
is
tr
a
te
d
o
ra
lly
Ik
e
ka
w
a
e
t
a
l.,
1
9
8
5
A
n
ti-
a
th
e
ro
sc
le
ro
tic
a
c
tiv
ity
M
e
th
a
n
o
l:d
ic
h
lo
ro
m
e
th
a
n
e
fr
a
c
tio
n
o
f
F.
ve
lu
ti
p
e
s
(c
o
n
ta
in
e
d
p
ro
to
c
a
te
c
h
u
ic
a
c
id
(1
),
p
-c
o
u
m
a
ric
(2
)
a
c
id
a
n
d
e
lla
g
ic
a
c
id
(3
)
In
vi
tr
o
la
g
tim
e
o
f
c
o
n
ju
g
a
te
d
d
ie
n
e
fo
rm
a
tio
n
in
L
D
L
m
o
le
c
u
le
a
n
d
T
B
A
R
S
in
h
ib
iti
o
n
a
ss
a
y
P
ro
lo
n
g
e
d
th
e
la
g
tim
e
o
f
C
D
fo
rm
a
tio
n
u
p
to
1
2
0
m
in
a
t
1
µ
g
/m
L
c
o
n
c
e
n
tr
a
tio
n
In
h
ib
ite
d
4
8
.7
1
%
o
f
T
B
A
R
S
fo
rm
a
tio
n
a
t
1
m
g
/m
L
c
o
n
c
e
n
tr
a
tio
n
R
a
h
m
a
n
e
t
a
l.,
2
0
1
5
T
h
ro
m
b
o
si
s
in
h
ib
ito
ry
a
c
tiv
ity
F
e
rm
e
n
te
d
e
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
C
o
a
g
u
la
b
ili
ty
te
st
,
th
ro
m
b
in
tim
e
F
ib
rin
o
ly
tic
a
c
tiv
ity
te
st
P
ro
lo
n
g
e
d
th
ro
m
b
in
c
lo
tt
in
g
tim
e
fo
r
3
5
8
.6
±
0
.4
s
(2
.2
×
c
o
n
tr
o
l)
D
e
m
o
n
st
ra
te
d
fib
rin
o
ly
tic
a
c
tiv
ity
o
n
fib
rin
p
la
te
w
ith
c
le
a
r
zo
n
e
o
f
2
0
±
0
.5
m
m
2
O
ka
m
u
ra
e
t
a
l.,
2
0
0
1
F
ib
rin
o
ly
tic
e
n
zy
m
e
is
o
la
te
d
fr
o
m
c
u
ltu
re
su
p
e
rn
a
ta
n
t
o
f
F.
ve
lu
ti
p
e
s
F
ib
rin
o
ly
tic
a
n
d
fib
rin
o
g
e
n
o
ly
tic
a
ss
a
ys
(S
D
S
-P
A
G
E
a
n
a
ly
si
s)
H
yd
ro
ly
ze
d
fib
rin
α
-c
h
a
in
fo
llo
w
e
d
b
y
th
e
γ
-γ
c
h
a
in
a
n
d
β
-c
h
a
in
(s
im
ila
r
h
yd
ro
ly
si
s
p
a
tt
e
rn
a
s
o
f
p
la
sm
in
)
H
yd
ro
ly
ze
d
A
α
-
a
n
d
B
β
-
c
h
a
in
s
o
f
fib
rin
o
g
e
n
P
a
rk
e
t
a
l.,
2
0
0
7
(C
o
n
ti
n
u
e
d
)
Frontiers in Pharmacology | www.frontiersin.org 8 December 2016 | Volume 7 | Article 474
Tang et al. Flammulina velutipes
T
A
B
L
E
6
|
C
o
n
ti
n
u
e
d
B
io
a
c
ti
v
it
ie
s
Te
s
te
d
s
u
b
s
ta
n
c
e
E
x
p
e
ri
m
e
n
ta
l
d
e
s
ig
n
D
o
s
a
g
e
a
n
d
re
s
u
lt
s
R
e
fe
re
n
c
e
s
C
h
o
le
st
e
ro
l-
lo
w
e
rin
g
e
ffe
c
t
a
n
d
a
n
tih
yp
e
rt
e
n
si
ve
a
c
tiv
ity
F.
ve
lu
ti
p
e
s
p
o
w
d
e
r
(F
V
P
)
a
n
d
w
a
te
r
e
xt
ra
c
t
(F
V
E
)
M
a
le
S
yr
ia
n
h
a
m
st
e
rs
u
n
d
e
r
h
ig
h
c
h
o
le
st
e
ro
ld
ie
t
(li
p
o
p
ro
te
in
s
d
e
te
rm
in
a
tio
n
)
R
e
d
u
c
e
d
le
ve
ls
o
f
se
ru
m
T
C
(2
8
.7
%
),
T
G
(3
3
.6
%
),
L
D
L
(5
4
.5
%
)
a
n
d
L
D
L
/H
D
L
ra
tio
n
(6
1
.8
%
)
a
n
d
a
ls
o
liv
e
r
T
C
(3
7
.6
%
)
a
n
d
T
G
(4
6
.1
%
)
o
f
h
ig
h
c
h
o
le
st
e
ro
l
d
ie
t
h
a
m
st
e
rs
su
p
p
le
m
e
n
te
d
w
ith
3
%
o
f
F
V
P
R
e
d
u
c
e
d
le
ve
ls
o
f
se
ru
m
T
C
(2
7
.0
%
),
T
G
(2
8
.6
%
),
L
D
L
(4
8
.5
%
)
a
n
d
L
D
L
/H
D
L
ra
tio
n
(5
7
.9
%
)
a
n
d
a
ls
o
liv
e
r
T
C
a
n
d
T
G
o
f
h
ig
h
c
h
o
le
st
e
ro
ld
ie
t
h
a
m
st
e
rs
su
p
p
le
m
e
n
te
d
w
ith
3
%
o
f
F
V
E
Y
e
h
e
t
a
l.,
2
0
1
4
E
xo
p
o
ly
m
e
r
e
xt
ra
c
te
d
fr
o
m
m
yc
e
liu
m
c
u
ltu
re
S
p
ra
g
u
e
-D
a
w
le
y
m
a
le
ra
t
u
n
d
e
r
h
yp
e
rli
p
id
e
m
ic
d
ie
t
R
e
d
u
c
e
d
th
e
p
la
sm
a
tr
ig
ly
c
e
rid
e
(2
0
.2
%
),
T
C
(2
1
.7
%
),
L
D
L
(2
7
.6
%
)
a
n
d
liv
e
r
T
C
(2
1
.4
%
)
in
h
yp
e
rli
p
id
e
m
ic
ra
t
a
t
1
0
0
g
/k
g
b
o
d
y
w
e
ig
h
t
fo
r
4
w
e
e
ks
Y
a
n
g
e
t
a
l.,
2
0
0
2
F.
ve
lu
ti
p
e
s
fib
e
r
M
a
le
F
3
4
4
/D
u
C
rj
ra
ts
R
e
d
u
c
e
d
le
ve
ls
o
f
se
ru
m
T
C
(9
.9
3
%
),
a
n
d
V
L
D
L
+
ID
L
+
L
D
L
(2
0
.6
%
)
w
h
e
n
fe
d
w
ith
5
0
g
/k
g
fo
r
4
w
e
e
ks
a
s
c
o
m
p
a
re
d
to
c
o
n
tr
o
lf
e
d
w
ith
c
e
llu
lo
se
d
ie
t
o
n
ly
F
u
ku
sh
im
a
e
t
a
l.,
2
0
0
1
G
A
B
A
(6
–7
%
)
p
ro
d
u
c
e
d
b
y
F.
ve
lu
ti
p
e
s
S
p
o
n
ta
n
e
o
u
sl
y
h
yp
e
rt
e
n
si
ve
ra
ts
L
o
w
e
re
d
th
e
sy
st
o
lic
b
lo
o
d
p
re
ss
u
re
b
y
∼
3
0
m
m
H
g
a
t
0
.9
m
g
G
A
B
A
/k
g
H
a
ra
d
a
e
t
a
l.,
2
0
1
1
M
yc
e
liu
m
c
u
ltu
re
o
f
F.
ve
lu
ti
p
e
s
In
vi
tr
o
A
C
E
in
h
ib
ito
ry
a
ss
a
y
S
h
o
w
e
d
st
ro
n
g
A
C
E
in
h
ib
ito
ry
e
ffe
c
t
fr
o
m
4
0
.7
to
5
2
.8
%
w
ith
IC
5
0
fr
o
m
7
.4
to
2
2
.6
m
g
/m
L
c
o
m
p
a
re
d
to
o
th
e
r
b
a
si
d
io
m
yc
e
te
s
c
u
ltu
re
s
K
im
e
t
a
l.,
2
0
0
2
M
e
m
o
ry
a
n
d
le
a
rn
in
g
im
p
ro
ve
m
e
n
t
P
o
ly
sa
c
c
h
a
rid
e
s
e
xt
ra
c
te
d
fr
o
m
F.
ve
lu
ti
p
e
s
S
c
o
p
o
la
m
in
e
-i
n
d
u
c
e
d
m
e
m
o
ry
a
n
d
le
a
rn
in
g
im
p
a
ire
d
ra
t
m
o
d
e
l
In
c
re
a
se
d
S
O
D
a
n
d
G
S
H
-P
x
a
c
tiv
iti
e
s
in
th
e
b
ra
in
;
in
h
ib
ite
d
T
B
A
R
S
fo
rm
a
tio
n
in
th
e
b
ra
in
fr
o
m
1
0
0
to
4
0
0
µ
g
/k
g
R
e
st
o
re
d
th
e
n
e
u
ro
tr
a
n
sm
itt
e
rs
(D
A
,
N
E
,
5
-H
T
a
n
d
A
c
h
)
le
ve
li
n
th
e
b
ra
in
o
f
sc
o
p
o
la
m
in
e
tr
e
a
te
d
ra
t
In
c
re
a
se
d
th
e
e
xp
re
ss
io
n
o
f
p
-C
a
M
K
II
a
n
d
c
o
n
n
e
xi
n
3
6
in
th
e
b
ra
in
Y
a
n
g
e
t
a
l.,
2
0
1
5
W
a
te
r
e
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
a
n
d
p
o
ly
sa
c
c
h
a
rid
e
s
e
xt
ra
c
te
d
fr
o
m
th
e
w
a
te
r
e
xt
ra
c
t
w
ith
u
ltr
a
so
n
ic
In
vi
tr
o
A
C
h
E
in
h
ib
ito
ry
a
c
tiv
ity
W
a
te
r
e
xt
ra
c
t
d
e
m
o
n
st
ra
te
d
∼
2
0
%
A
C
h
E
in
h
ib
ito
ry
e
ffe
c
t
T
h
e
F
V
P
e
xt
ra
c
te
d
u
si
n
g
u
ltr
a
so
n
ic
d
is
p
la
ye
d
A
C
h
E
in
h
ib
ito
ry
ra
te
o
f
1
8
.5
1
%
a
t
0
.6
m
g
/m
l
Y
a
n
g
e
t
a
l.,
2
0
1
1
R
ib
o
so
m
e
in
a
c
tiv
a
tin
g
p
ro
te
in
V
e
lu
tin
E
L
IS
A
ki
t—
g
ly
c
o
h
yd
ro
la
se
in
h
ib
ito
ry
a
c
tiv
ity
a
ss
a
y
C
e
ll-
fr
e
e
ra
b
b
it
re
tic
u
lo
c
yt
e
ly
sa
te
sy
st
e
m
A
t
5
m
g
/m
L
,
ve
lu
tin
sh
o
w
e
d
in
h
ib
iti
o
n
a
g
a
in
st
H
IV
-1
re
ve
rs
e
tr
a
n
sc
rip
ta
se
,
α
-g
lu
c
o
si
d
a
se
,
β
-g
lu
c
o
si
d
a
se
a
n
d
β
-g
lu
c
u
ro
n
id
a
se
fo
r
1
0
2
.3
,
8
.3
,
6
2
.3
a
n
d
6
4
.7
%
,
re
sp
e
c
tiv
e
ly
C
e
ll-
fr
e
e
tr
a
n
sl
a
tio
n
-i
n
h
ib
ito
ry
a
c
tiv
ity
(p
re
ve
n
te
d
p
ro
te
in
sy
n
th
e
si
s
o
f
3
H
-l
e
u
c
in
e
a
t
IC
5
0
o
f
0
.2
9
n
M
)
W
a
n
g
a
n
d
N
g
,
2
0
0
1
F
la
m
m
in
C
e
ll-
fr
e
e
ra
b
b
it
re
tic
u
lo
c
yt
e
ly
sa
te
sy
st
e
m
In
h
ib
ite
d
tr
a
n
sl
a
tio
n
a
t
IC
5
0
o
f
1
.4
n
M
N
g
a
n
d
W
a
n
g
,
2
0
0
4
V
e
lin
C
e
ll-
fr
e
e
ra
b
b
it
re
tic
u
lo
c
yt
e
ly
sa
te
sy
st
e
m
In
h
ib
ite
d
tr
a
n
sl
a
tio
n
a
t
IC
5
0
o
f
2
.5
n
M
N
g
a
n
d
W
a
n
g
,
2
0
0
4
F
la
m
m
u
lin
a
C
e
ll-
fr
e
e
ra
b
b
it
re
tic
u
lo
c
yt
e
ly
sa
te
sy
st
e
m
In
h
ib
ite
d
3
H
-l
e
u
c
in
e
in
c
o
rp
o
ra
tio
n
in
to
p
ro
te
in
a
t
IC
5
0
o
f
0
.2
5
n
M
W
a
n
g
a
n
d
N
g
,
2
0
0
0
A
n
tio
xi
d
a
n
t
a
c
tiv
ity
In
tr
a
c
e
llu
la
r
p
o
ly
sa
c
c
h
a
rid
e
s
fr
o
m
F.
ve
lu
ti
p
e
s
m
yc
e
liu
m
S
F
-0
8
In
vi
tr
o
a
n
tio
xi
d
a
n
t
a
ss
a
ys
–D
P
P
H
,
su
p
e
ro
xi
d
e
,
h
yd
ro
xy
la
n
d
re
d
u
c
in
g
p
o
w
e
r
a
ss
a
ys
In
vi
vo
a
n
tio
xi
d
a
n
t
st
a
tu
s–
S
O
D
,
G
S
H
-P
x
a
n
d
L
P
O
a
ss
a
ys
D
P
P
H
sc
a
ve
n
g
in
g
a
c
tiv
ity
re
a
c
h
e
d
u
p
to
6
6
.3
8
%
a
t
1
µ
g
/m
L
S
u
p
e
ro
xi
d
e
sc
a
ve
n
g
in
g
a
c
tiv
ity
re
a
c
h
e
d
u
p
to
8
4
.2
9
%
a
t
1
µ
g
/m
L
H
yd
ro
xy
lr
a
d
ic
a
ls
c
a
ve
n
g
in
g
a
c
tiv
ity
re
a
c
h
e
d
u
p
to
8
4
.4
2
%
a
t
1
µ
g
/m
L
R
e
d
u
c
in
g
p
o
w
e
r
re
a
c
h
e
d
u
p
to
1
.5
6
a
t
1
µ
g
/m
L
In
c
re
a
se
d
S
O
D
a
n
d
G
S
H
-P
x
a
c
tiv
iti
e
s
a
n
d
d
e
c
re
a
se
d
L
P
O
le
ve
li
n
a
ll
h
e
a
rt
,
ki
d
n
e
y
a
n
d
b
lo
o
d
a
t
8
0
0
m
g
/k
g
b
o
d
y
w
e
ig
h
t
o
f
m
ic
e
a
d
m
in
is
tr
a
te
d
o
ra
lly
M
a
e
t
a
l.,
2
0
1
5
b
E
xo
p
o
ly
sa
c
c
h
a
rid
e
e
xt
ra
c
te
d
fr
o
m
c
u
ltu
re
o
f
F.
ve
lu
ti
p
e
s
S
F
-0
6
In
vi
tr
o
a
n
tio
xi
d
a
n
t
a
ss
a
ys
—
D
P
P
H
,
su
p
e
ro
xi
d
e
,
h
yd
ro
xy
la
n
d
re
d
u
c
in
g
p
o
w
e
r
a
ss
a
ys
In
vi
vo
a
n
tio
xi
d
a
n
t
st
a
tu
s—
c
a
ta
la
se
a
n
d
T
B
A
R
S
a
ss
a
ys
D
P
P
H
sc
a
ve
n
g
in
g
a
c
tiv
ity
re
a
c
h
e
d
u
p
to
6
4
.5
3
%
a
t
1
µ
g
/m
L
S
u
p
e
ro
xi
d
e
sc
a
ve
n
g
in
g
a
c
tiv
ity
re
a
c
h
e
d
u
p
to
6
7
.6
4
%
a
t
1
µ
g
/m
L
H
yd
ro
xy
lr
a
d
ic
a
ls
c
a
ve
n
g
in
g
a
c
tiv
ity
re
a
c
h
e
d
u
p
to
∼
8
0
.0
%
a
t
1
µ
g
/m
L
R
e
d
u
c
in
g
p
o
w
e
r
re
a
c
h
e
d
u
p
to
1
.4
5
a
t
1
µ
g
/m
L
In
c
re
a
se
d
c
a
ta
la
se
a
c
tiv
ity
a
n
d
d
e
c
re
a
se
d
T
B
A
R
S
fo
rm
a
tio
n
in
a
ll
h
e
a
rt
,
ki
d
n
e
y
a
n
d
b
lo
o
d
a
t
8
0
0
m
g
/k
g
b
o
d
y
w
e
ig
h
t
o
f
m
ic
e
a
d
m
in
is
tr
a
te
d
o
ra
lly
M
a
e
t
a
l.,
2
0
1
5
a
O
lig
o
sa
c
c
h
a
rid
e
s
fr
o
m
F.
ve
lu
ti
p
e
s
In
vi
tr
o
a
n
tio
xi
d
a
n
t
a
ss
a
ys
—
h
yd
ro
xy
ls
c
a
ve
n
g
in
g
a
n
d
re
d
u
c
in
g
p
o
w
e
r
a
ss
a
ys
H
yd
ro
xy
ls
c
a
ve
n
g
in
g
a
c
tiv
ity
re
a
c
h
e
d
u
p
to
8
0
.2
4
%
a
t
1
0
0
µ
g
/m
L
R
e
d
u
c
in
g
p
o
w
e
r
re
a
c
h
e
d
u
p
to
0
.8
5
6
a
t
1
0
0
µ
g
/m
L
X
ia
,
2
0
1
5
W
a
te
r-
so
lu
b
le
p
o
ly
sa
c
c
h
a
rid
e
In
vi
tr
o
a
n
tio
xi
d
a
n
t
a
ss
a
ys
—
su
p
e
ro
xi
d
e
ra
d
ic
a
l
sc
a
ve
n
g
in
g
,
h
yd
ro
xy
lr
a
d
ic
a
ls
c
a
ve
n
g
in
g
a
n
d
re
d
u
c
in
g
p
o
w
e
r
a
ss
a
ys
S
u
p
e
ro
xi
d
e
ra
d
ic
a
ls
c
a
ve
n
g
in
g
a
c
tiv
ity
w
ith
a
n
IC
5
0
o
f
∼
1
0
m
g
/m
L
H
yd
ro
xy
l
sc
a
ve
n
g
in
g
a
c
tiv
ity
w
ith
a
n
IC
5
0
o
f
∼
1
2
m
g
/m
L
D
e
m
o
n
st
ra
te
d
re
d
u
c
in
g
p
o
w
e
r
o
f
1
.0
4
a
t
5
m
g
/m
L
W
u
e
t
a
l.,
2
0
1
4
(C
o
n
ti
n
u
e
d
)
Frontiers in Pharmacology | www.frontiersin.org 9 December 2016 | Volume 7 | Article 474
Tang et al. Flammulina velutipes
T
A
B
L
E
6
|
C
o
n
ti
n
u
e
d
B
io
a
c
ti
v
it
ie
s
Te
s
te
d
s
u
b
s
ta
n
c
e
E
x
p
e
ri
m
e
n
ta
l
d
e
s
ig
n
D
o
s
a
g
e
a
n
d
re
s
u
lt
s
R
e
fe
re
n
c
e
s
P
o
ly
sa
c
c
h
a
rid
e
e
xt
ra
c
te
d
fr
o
m
m
yc
e
lia
o
f
F.
ve
lu
ti
p
e
s
In
vi
tr
o
a
n
tio
xi
d
a
n
t
a
ss
a
ys
—
D
P
P
H
sc
a
ve
n
g
in
g
a
n
d
h
yd
ro
xy
lr
a
d
ic
a
ls
c
a
ve
n
g
in
g
a
c
tiv
iti
e
s
D
P
P
H
sc
a
ve
n
g
in
g
a
c
tiv
ity
re
a
c
h
e
d
u
p
to
6
5
.5
8
%
a
t
2
0
0
µ
g
/m
L
H
yd
ro
xy
l
sc
a
ve
n
g
in
g
a
c
tiv
ity
re
a
c
h
e
d
u
p
to
7
1
.2
4
%
a
t
7
1
.2
4
µ
g
/m
L
Z
h
a
o
e
t
a
l.,
2
0
1
3
M
e
th
a
n
o
le
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
To
ta
lp
h
e
n
o
lic
c
o
n
te
n
t,
in
vi
tr
o
a
n
tio
xi
d
a
n
t
a
ss
a
ys
—
Tr
o
lo
x
e
q
u
iv
a
le
n
t
a
n
tio
xi
d
a
n
t
c
a
p
a
c
ity
,
fe
rr
ic
re
d
u
c
in
g
p
o
w
e
r
a
n
d
fe
rr
o
u
s
io
n
c
h
e
la
tin
g
a
c
tiv
iti
e
s
C
o
n
ta
in
e
d
2
.8
2
3
m
g
G
A
E
/g
e
xt
ra
c
t,
h
ig
h
e
st
a
m
o
n
g
th
e
th
re
e
o
th
e
r
m
u
sh
ro
o
m
s
sp
e
c
ie
s
E
xh
ib
ite
d
2
2
1
µ
m
o
lT
E
/g
e
xt
ra
c
t,
1
3
8
µ
m
o
lF
e
[II
]-
E
/g
e
xt
ra
c
t
a
n
d
5
2
4
µ
m
o
lE
D
TA
-E
/g
e
xt
ra
c
t
Z
e
n
g
e
t
a
l.,
2
0
1
2
W
a
te
r
so
lu
b
le
n
u
c
le
o
tid
e
e
xt
ra
c
t
fr
o
m
F.
ve
lu
ti
p
e
s
In
vi
tr
o
a
n
tio
xi
d
a
n
t
a
ss
a
ys
—
A
B
T
S
sc
a
ve
n
g
in
g
a
n
d
to
ta
lr
e
d
u
c
in
g
a
b
ili
ty
To
ta
lr
e
d
u
c
in
g
p
o
w
e
r
o
f
∼
0
.3
a
t
2
0
m
g
/m
L
E
xh
ib
ite
d
A
B
T
S
sc
a
ve
n
g
in
g
ra
te
o
f
∼
4
0
%
a
t
2
0
m
g
/m
L
C
h
e
n
g
e
t
a
l.,
2
0
1
2
E
n
o
ki
p
o
d
in
B
(2
2
)
E
n
o
ki
p
o
d
in
D
(2
3
)
E
n
o
ki
p
o
d
in
J
(3
0
)
2
,5
-c
u
p
a
ra
d
ie
n
e
-1
,4
-d
io
n
e
(2
4
)
In
vi
tr
o
a
n
tio
xi
d
a
n
t
a
ss
a
y—
D
P
P
H
sc
a
ve
n
g
in
g
a
c
tiv
ity
E
n
o
ki
p
o
d
in
J
(3
0
)
w
ith
IC
5
0
a
t
7
8
.6
µ
M
;
2
,5
-c
u
p
a
ra
d
ie
n
e
-1
,4
-d
io
n
e
(2
4
)
w
ith
IC
5
0
a
t
8
0
.7
µ
M
;
E
n
o
ki
p
o
d
in
B
(2
2
)
w
ith
IC
5
0
a
t
1
5
4
.2
µ
M
a
n
d
E
n
o
ki
p
o
d
in
D
(2
3
)
w
ith
IC
5
0
a
t
1
1
6
.5
µ
M
W
a
n
g
e
t
a
l.,
2
0
1
2
d
Im
m
u
n
o
m
o
d
u
la
to
ry
p
ro
p
e
rt
ie
s
F
IP
-f
ve
p
u
rifi
e
d
fr
o
m
e
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
In
vi
tr
o
e
xp
e
rim
e
n
t—
c
e
ll
p
ro
lif
e
ra
tio
n
a
ss
a
y
m
u
rin
e
sp
le
n
o
c
yt
e
s;
c
yt
o
ki
n
e
p
ro
fil
in
g
(E
L
IS
A
)
In
vi
vo
e
xp
e
rim
e
n
t—
fo
o
d
a
lle
rg
y
m
u
rin
e
m
o
d
e
l
(o
ra
ls
e
n
si
tiz
a
tio
n
b
y
o
va
lb
u
m
in
)
In
d
u
c
e
d
p
ro
lif
e
ra
tio
n
o
f
to
ta
lm
u
rin
e
sp
le
n
o
c
yt
e
s
a
n
d
o
n
ly
th
e
T
c
e
lls
th
a
t
is
A
P
C
-d
e
p
e
n
d
e
n
t
(c
o
-c
u
ltu
re
d
w
ith
irr
a
d
ia
te
d
sp
le
n
o
c
yt
e
s)
(1
0
–4
0
µ
g
/m
L
)
R
e
su
lte
d
T
h
1
-s
ke
w
e
d
im
m
u
n
e
re
sp
o
n
se
(p
ro
m
in
e
n
t
IF
N
-γ
;
lit
tle
r
o
r
n
o
IL
-4
p
ro
d
u
c
tio
n
in
th
e
su
p
e
rn
a
ta
n
t)
(1
0
–4
0
µ
g
/m
L
)
R
e
su
lte
d
in
c
re
a
se
d
se
ru
m
IF
N
-γ
in
m
ic
e
fe
d
w
ith
1
0
0
–4
0
0
µ
g
p
e
r
m
o
u
se
e
ve
ry
d
a
y
fo
r
8
d
a
ys
R
e
d
u
c
e
d
sy
st
e
m
ic
a
n
a
p
h
yl
a
xi
s-
lik
e
sy
m
p
to
m
sc
o
re
a
n
d
p
la
sm
a
h
is
ta
m
in
e
le
ve
li
n
O
V
A
c
h
a
lle
n
g
e
d
m
ic
e
tr
e
a
te
d
w
ith
F
IP
-f
ve
H
si
e
h
e
t
a
l.,
2
0
0
3
F
IP
-f
ve
p
u
rifi
e
d
fr
o
m
e
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
In
vi
tr
o
e
xp
e
rim
e
n
t—
c
e
ll
c
yc
le
a
n
a
ly
si
s,
c
yt
o
ki
n
e
a
n
a
ly
si
s
a
n
d
W
e
st
e
rn
b
lo
t
In
d
u
c
e
d
G
1
/G
0
to
S
p
h
a
se
p
ro
lif
e
ra
tio
n
in
P
B
M
C
a
t
1
0
0
µ
g
a
ft
e
r
7
2
h
In
c
re
a
se
d
IF
N
-γ
p
ro
d
u
c
tio
n
d
o
se
-d
e
p
e
n
d
e
n
tly
in
P
B
M
C
u
n
til
re
a
c
h
e
d
p
la
te
a
u
a
t
1
0
0
µ
g
/m
L
In
d
u
c
e
d
IC
A
M
-1
e
xp
re
ss
io
n
d
o
se
-d
e
p
e
n
d
e
n
tly
;
a
c
tiv
a
te
d
p
3
8
M
A
P
ki
n
a
se
(in
c
re
a
se
d
e
xp
re
ss
io
n
o
f
p
h
o
sp
h
o
-p
3
8
)
W
a
n
g
e
t
a
l.,
2
0
0
4
F
IP
-f
ve
p
u
rifi
e
d
fr
o
m
e
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
In
vi
tr
o
e
xp
e
rim
e
n
t—
C
a
2
+
a
n
a
ly
si
s,
W
e
st
e
rn
b
lo
t
a
n
d
R
T-
P
C
R
C
a
u
se
d
e
le
va
tio
n
o
f
in
tr
a
c
e
llu
la
r
C
a
2
+
c
o
n
c
e
n
tr
a
tio
n
re
le
a
se
in
P
B
M
C
(in
c
re
a
se
tr
a
n
si
e
n
tly
a
t
3
0
s
a
ft
e
r
tr
e
a
te
d
w
ith
F
IP
-f
ve
a
n
d
re
a
c
h
e
d
m
a
xi
m
u
m
a
t
7
0
s)
M
a
xi
m
u
m
a
c
tiv
a
tio
n
o
f
P
K
C
-α
a
t
3
h
in
c
u
b
a
tio
n
w
ith
7
.6
9
µ
M
c
o
n
c
e
n
tr
a
tio
n
In
c
re
a
se
d
e
xp
re
ss
io
n
o
f
IF
N
-γ
m
R
N
A
u
p
o
n
tr
e
a
tm
e
n
t
w
ith
F
IP
-f
ve
a
t7
.6
9
µ
M
fo
r
4
8
h
O
u
e
t
a
l.,
2
0
0
9
F
IP
-f
ve
In
vi
tr
o
e
xp
e
rim
e
n
t—
e
o
si
n
o
p
h
il
su
rv
iv
a
lu
n
d
e
r
IL
-5
(a
p
o
p
to
si
s
a
n
a
ly
si
s)
,
a
p
o
p
to
tic
p
ro
te
in
e
xp
re
ss
io
n
(fl
o
w
c
yt
o
m
e
tr
y)
,
R
T-
P
C
R
R
e
d
u
c
e
d
th
e
p
ro
te
c
tiv
e
e
ffe
c
t
o
f
IL
-5
fo
r
e
o
si
n
o
p
h
ils
fr
o
m
a
p
o
p
to
si
s
(a
t
1
0
a
n
d
2
5
µ
g
/m
L
),
in
c
re
a
se
d
in
e
a
rly
a
p
o
p
to
tic
a
n
d
la
te
a
p
o
p
to
tic
e
o
si
n
o
p
h
ils
D
im
in
is
h
e
d
th
e
a
n
ti-
a
p
o
p
to
tic
B
c
l-
2
in
e
o
si
n
o
p
h
il
st
im
u
la
te
d
w
ith
IL
-5
w
h
e
n
tr
e
a
te
d
w
ith
F
IP
-f
ve
D
o
w
n
re
g
u
la
te
d
IL
-5
R
α
p
ro
te
in
s
a
n
d
m
R
N
A
e
xp
re
ss
io
n
o
n
e
o
si
n
o
p
h
ils
H
si
e
h
e
t
a
l.,
2
0
0
7
F
IP
-f
ve
p
u
rifi
e
d
fr
o
m
e
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
In
vi
vo
e
xp
e
rim
e
n
t—
m
o
u
se
m
o
d
e
lo
f
a
lle
rg
ic
a
st
h
m
a
(s
e
n
si
tiz
a
tio
n
to
O
V
A
in
tr
a
p
e
rit
o
n
e
a
lly
1
st
to
1
4
th
d
a
y,
fo
llo
w
e
d
b
y
in
tr
a
n
a
sa
lc
h
a
lle
n
g
e
3
%
O
V
A
)
B
o
th
p
re
-t
re
a
tm
e
n
t
a
n
d
p
o
st
-t
re
a
tm
e
n
t
o
f
F
IP
-f
ve
su
p
p
re
ss
e
d
a
irw
a
y
h
yp
e
ra
c
tiv
ity
(a
ss
e
ss
e
d
w
ith
w
h
o
le
-b
o
d
y
b
a
ro
m
e
tr
ic
p
le
th
ys
m
o
g
ra
p
h
y)
R
e
d
u
c
e
d
Ig
E
(5
4
.7
–5
8
.6
%
)
a
n
d
in
c
re
a
se
d
Ig
G
2
a
(8
3
.2
–1
4
4
.5
%
)
in
th
e
se
ru
m
D
e
c
re
a
se
d
T
h
2
c
yt
o
ki
n
e
s
(IL
-4
,
IL
-5
a
n
d
IL
-1
3
a
n
d
IL
-1
0
),
in
c
re
a
se
d
T
h
1
a
n
d
Tr
e
g
c
yt
o
ki
n
e
s
(IF
N
-γ
a
n
d
T
G
F
-β
)
in
th
e
se
ru
m
R
e
d
u
c
e
d
in
fla
m
m
a
tio
n
a
n
d
e
p
ith
e
lia
lc
e
ll
th
ic
kn
e
ss
(h
is
to
lo
g
ic
a
le
xa
m
in
a
tio
n
)
L
e
e
e
t
a
l.,
2
0
1
3
F
IP
-f
ve
p
u
rifi
e
d
fr
o
m
e
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
In
vi
vo
e
xp
e
rim
e
n
t—
m
o
u
se
m
o
d
e
ls
o
f
a
lle
rg
ic
a
st
h
m
a
(s
e
n
si
tiz
a
tio
n
to
H
D
M
o
r
D
M
in
tr
a
p
e
rit
o
n
e
a
lly
1
st
to
1
4
th
d
a
y,
fo
llo
w
e
d
b
y
in
tr
a
n
a
sa
lc
h
a
lle
n
g
e
5
0
µ
g
H
D
M
/D
M
)
R
e
d
u
c
e
d
a
irw
a
y
h
yp
e
rr
e
sp
o
n
si
ve
n
e
ss
(a
ss
e
ss
e
d
w
ith
w
h
o
le
-b
o
d
y
b
a
ro
m
e
tr
ic
p
le
th
ys
m
o
g
ra
p
h
y)
R
e
d
u
c
e
d
in
fil
tr
a
tin
g
c
e
lls
(e
o
si
n
o
p
h
ils
a
n
d
ly
m
p
h
o
c
yt
e
s)
in
m
ic
e
c
h
a
lle
n
g
e
d
b
y
H
D
M
o
r
D
M
u
p
o
n
tr
e
a
tm
e
n
t
w
ith
F
IP
-f
ve
A
t
h
u
m
o
ra
ll
e
ve
l,
in
c
re
a
se
d
Ig
G
2
a
w
h
ile
d
e
c
re
a
se
d
Ig
E
in
th
e
se
ru
m
R
e
d
u
c
e
d
T
h
2
c
yt
o
ki
n
e
s
w
h
ile
in
c
re
a
se
d
T
h
1
a
n
d
Tr
e
g
c
yt
o
ki
n
e
s
in
se
ru
m
a
n
d
B
A
L
F
R
e
d
u
c
e
d
in
fla
m
m
a
tio
n
a
n
d
e
p
ith
e
lia
lc
e
ll
th
ic
kn
e
ss
(h
is
to
lo
g
ic
a
le
xa
m
in
a
tio
n
)
C
h
a
n
g
e
t
a
l.,
2
0
1
5
;
C
h
u
e
t
a
l.,
2
0
1
5
(C
o
n
ti
n
u
e
d
)
Frontiers in Pharmacology | www.frontiersin.org 10 December 2016 | Volume 7 | Article 474
Tang et al. Flammulina velutipes
T
A
B
L
E
6
|
C
o
n
ti
n
u
e
d
B
io
a
c
ti
v
it
ie
s
Te
s
te
d
s
u
b
s
ta
n
c
e
E
x
p
e
ri
m
e
n
ta
l
d
e
s
ig
n
D
o
s
a
g
e
a
n
d
re
s
u
lt
s
R
e
fe
re
n
c
e
s
F
IP
-f
ve
p
u
rifi
e
d
fr
o
m
e
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
F
e
m
a
le
B
A
L
B
/c
m
ic
e
w
ith
R
S
V
in
tr
a
n
a
sa
l
c
h
a
lle
n
g
e
(2
×
1
0
5
P
F
U
)
In
vi
tr
o
e
xp
e
rim
e
n
t—
p
la
q
u
e
fo
rm
a
tio
n
a
ss
a
y
(H
E
p
-2
c
e
ll)
,
R
T-
P
C
R
F
IP
-f
ve
a
d
m
in
is
tr
a
te
d
o
ra
lly
(2
d
a
ys
b
e
fo
re
to
6
d
a
ys
a
ft
e
r
R
S
V
in
fe
c
tio
n
)—
d
e
c
re
a
se
d
a
irw
a
y
h
yp
e
rr
e
a
c
tiv
ity
R
e
d
u
c
e
d
IL
-6
w
h
ile
in
c
re
a
se
d
IF
N
-γ
R
e
d
u
c
e
d
R
S
V
in
fe
c
tio
n
ra
te
in
lu
n
g
tis
su
e
s
In
h
ib
ite
d
p
la
q
u
e
fo
rm
a
tio
n
(fr
o
m
1
1
1
.0
p
la
q
u
e
c
o
u
n
t
to
1
7
.3
a
n
d
0
a
t
7
.5
µ
M
a
n
d
3
0
M
m
,
re
sp
e
c
tiv
e
ly
D
e
c
re
a
se
d
IL
-6
m
R
N
A
e
xp
re
ss
io
n
C
h
a
n
g
e
t
a
l.,
2
0
1
4
F
IP
-f
ve
p
u
rifi
e
d
fr
o
m
e
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
In
vi
vo
e
xp
e
rim
e
n
t—
n
e
u
tr
o
p
e
n
ia
m
o
u
se
m
o
d
e
l
in
d
u
c
e
d
b
y
d
o
c
e
ta
xe
l
1
0
m
g
/k
g
m
o
u
se
fo
r
3
d
a
ys
(o
ra
lg
a
va
g
e
)
b
e
fo
re
d
o
c
e
ta
xe
l
in
je
c
tio
n
—
re
st
o
re
d
d
o
c
e
ta
xa
l-
in
d
u
c
e
d
m
ye
lo
to
xi
c
ity
(e
le
va
te
d
h
e
m
o
g
lo
b
in
le
ve
l),
p
ro
te
c
te
d
th
e
b
o
n
e
m
a
rr
o
w
a
n
d
h
a
e
m
a
to
p
o
ie
tic
c
e
lls
fr
o
m
d
a
m
a
g
e
s
b
y
d
o
c
e
ta
xe
l,
p
re
ve
n
te
d
d
a
m
a
g
e
s
o
n
th
e
b
o
n
e
m
ic
ro
e
n
vi
ro
n
m
e
n
t
P
a
rt
ia
lp
ro
te
c
tio
n
fo
r
in
te
st
in
a
lv
ill
ia
g
a
in
st
d
o
c
e
ta
xe
l-
in
d
u
c
e
d
in
te
rs
tin
a
li
n
ju
rie
s
O
u
e
t
a
l.,
2
0
1
5
P
o
ly
sa
c
c
h
a
rid
e
p
u
rifi
e
d
fr
o
m
F.
ve
lu
ti
p
e
s
m
yc
e
liu
m
In
vi
tr
o
e
xp
e
rim
e
n
t—
N
O
p
ro
d
u
c
tio
n
a
ss
a
y,
T
N
F
-α
p
ro
d
u
c
tio
n
a
ss
a
y
a
n
d
IL
-1
E
L
IS
A
E
n
h
a
n
c
e
d
N
O
,
T
N
F
-α
,
IL
-1
p
ro
d
u
c
tio
n
b
y
m
a
c
ro
p
h
a
g
e
s
in
a
d
o
se
d
e
p
e
n
d
e
n
t
m
a
n
n
e
r
Y
in
e
t
a
l.,
2
0
1
0
P
o
ly
sa
c
c
h
a
rid
e
d
e
riv
e
d
fr
o
m
F.
ve
lu
ti
p
e
s
m
yc
o
rr
h
iz
a
e
(P
F
V
M
)
In
vi
vo
e
xp
e
rim
e
n
t—
o
ra
lg
a
va
g
e
o
f
P
F
V
M
tw
ic
e
a
d
a
y
fo
r
6
0
d
a
ys
o
n
fe
m
a
le
W
is
te
r
m
ic
e
,
w
e
ig
h
t
ra
tio
o
f
th
ym
u
s
a
n
d
sp
le
e
n
,
flo
w
c
yt
o
m
e
tr
y,
c
yt
o
ki
n
e
p
ro
fil
e
In
vi
tr
o
e
xp
e
rim
e
n
t—
is
o
la
tio
n
o
f
m
ic
e
sp
le
e
n
ly
m
p
h
o
c
yt
e
s,
M
T
T
In
c
re
a
se
d
th
e
w
e
ig
h
t
ra
tio
o
f
th
ym
u
s
a
n
d
sp
le
e
n
a
t
d
o
se
s
o
f
2
g
/k
g
a
n
d
4
g
/k
g
,
re
sp
e
c
tiv
e
ly
In
c
re
a
se
d
th
e
p
e
rc
e
n
ta
g
e
o
f
C
D
3
+
a
n
d
C
D
4
+
th
ym
o
c
yt
e
s
d
o
se
-d
e
p
e
n
d
e
n
tly
in
th
e
p
e
rip
h
e
ra
lb
lo
o
d
,
th
ym
u
s,
sp
le
e
n
o
f
th
e
m
ic
e
In
c
re
a
se
d
IL
-2
a
n
d
T
N
F
-α
in
th
e
se
ru
m
d
o
se
-d
e
p
e
n
d
e
n
tly
In
c
re
a
se
d
th
e
p
e
rc
e
n
ta
g
e
o
f
C
D
3
+
,
C
D
4
+
a
n
d
ra
tio
o
f
C
D
4
+
/C
D
8
+
in
sp
le
e
n
ly
m
p
h
o
c
yt
e
s
Y
a
n
e
t
a
l.,
2
0
1
4
W
a
te
r-
so
lu
b
le
p
o
ly
sa
c
c
h
a
rid
e
fr
o
m
F.
ve
lu
ti
p
e
s
In
vi
tr
o
e
xp
e
rim
e
n
t—
N
O
p
ro
d
u
c
tio
n
a
ss
a
y,
IL
-1
,
IL
-6
a
n
d
T
N
F
-α
E
L
IS
A
a
n
d
ly
m
p
h
o
c
yt
e
p
ro
lif
e
ra
tio
n
a
ss
a
y
In
c
re
a
se
d
th
e
N
O
p
ro
d
u
c
tio
n
fr
o
m
m
a
c
ro
p
h
a
g
e
s
d
o
se
-d
e
p
e
n
d
e
n
tly
fr
o
m
5
to
1
6
0
µ
g
/m
L
In
c
re
a
se
d
p
ro
d
u
c
tio
n
o
f
IL
-1
β
a
t
2
0
µ
g
/m
L
w
h
ile
in
c
re
a
se
d
p
ro
d
u
c
tio
n
o
f
IL
-6
a
n
d
T
N
F
-α
a
t
5
µ
g
/m
L
P
ro
m
o
te
d
ly
m
p
h
o
c
yt
e
s
p
ro
lif
e
ra
tio
n
fr
o
m
5
0
to
5
0
0
µ
g
/m
L
in
d
o
se
-d
e
p
e
n
d
e
n
t
m
a
n
n
e
r
W
u
e
t
a
l.,
2
0
1
4
W
a
te
r
e
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
In
vi
tr
o
e
xp
e
rim
e
n
t—
p
ro
lif
e
ra
tio
n
a
ss
a
y,
c
yt
o
ki
n
e
p
ro
fil
e
In
c
re
a
se
d
p
ro
lif
e
ra
tio
n
o
f
sp
le
n
o
c
yt
e
s
a
t
c
o
n
c
e
n
tr
a
tio
n
s
ra
n
g
in
g
fr
o
m
1
0
to
1
0
0
0
µ
g
/m
L
In
c
re
a
se
d
T
h
1
c
yt
o
ki
n
e
p
ro
d
u
c
tio
n
s
R
yu
e
t
a
l.,
2
0
1
4
B
o
ili
n
g
w
a
te
r
e
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
In
vi
tr
o
e
xp
e
rim
e
n
t—
c
yt
o
ki
n
e
p
ro
fil
e
(E
L
IS
A
),
c
yt
o
to
xi
c
ity
a
ss
a
y
S
tim
u
la
te
d
th
e
p
ro
d
u
c
tio
n
o
f
IF
N
-γ
fr
o
m
la
rg
e
in
te
st
in
a
ll
a
m
in
a
p
ro
p
ria
le
u
ko
c
yt
e
s
P
ro
m
o
te
d
th
e
c
yt
o
to
xi
c
ity
o
f
la
rg
e
in
te
st
in
a
ll
a
m
in
a
p
ro
p
ria
le
u
ko
c
yt
e
s
is
o
la
te
d
fr
o
m
ra
t
a
g
a
in
st
Y
A
C
-1
c
e
lls
L
e
e
e
t
a
l.,
2
0
1
1
M
e
la
n
o
si
s
in
h
ib
ito
ry
a
c
tiv
ity
E
rg
o
th
io
n
e
in
e
(3
4
)
c
o
n
ta
in
in
g
h
o
t
w
a
te
r
e
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
In
vi
tr
o
e
xp
e
rim
e
n
t—
m
u
sh
ro
o
m
p
o
ly
p
h
e
n
o
l
o
xi
d
a
se
in
h
ib
iti
o
n
a
ss
a
y,
R
T-
P
C
R
In
vi
vo
e
xp
e
rim
e
n
t—
Im
m
e
rs
io
n
tr
e
a
tm
e
n
t,
p
o
st
h
a
rv
e
st
m
e
la
n
o
si
s
In
h
ib
ite
d
m
u
sh
ro
o
m
p
o
ly
p
h
e
n
o
lo
xi
d
a
se
a
c
tiv
ity
b
y
5
8
%
a
ft
e
r
3
0
0
s
a
t
0
.3
8
m
g
e
rg
o
th
io
n
e
in
e
/m
L
e
xt
ra
c
t,
a
n
d
in
a
d
o
se
-d
e
p
e
n
d
e
n
t
m
a
n
n
e
r
L
o
w
e
re
d
e
xp
re
ss
io
n
o
f
p
ro
P
O
g
e
n
e
in
g
ro
u
p
fe
d
w
ith
F.
ve
lu
ti
p
e
s
e
xt
ra
c
t
S
u
p
p
re
ss
e
d
th
e
p
o
ly
p
h
e
n
o
lo
xi
d
a
se
a
c
tiv
ity
in
th
e
h
e
m
o
ly
m
p
h
s
o
f
th
e
o
rg
a
n
is
m
s
su
p
p
le
m
e
n
te
d
w
ith
F.
ve
lu
ti
p
e
s
e
xt
ra
c
t
d
ie
t
(2
5
%
in
w
e
t
d
ie
t
e
a
c
h
d
a
y
fo
r
7
d
a
ys
)
0
.5
%
F.
ve
lu
ti
p
e
s
e
xt
ra
c
t
in
im
m
e
rs
in
g
so
lu
tio
n
p
re
ve
n
te
d
m
e
la
n
o
si
s
in
th
e
c
a
ra
p
a
c
e
d
u
rin
g
ic
e
st
o
ra
g
e
E
n
c
a
rn
a
c
io
n
e
t
a
l.,
2
0
1
0
,
2
0
1
1
a
,b
;
E
n
c
a
rn
a
c
io
n
e
t
a
l.,
2
0
1
2
E
rg
o
th
io
n
e
in
e
(3
4
)
c
o
n
ta
in
in
g
h
o
t
w
a
te
r
e
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
In
vi
tr
o
e
xp
e
rim
e
n
t—
to
ta
ll
ip
id
h
yd
ro
p
e
ro
xi
d
e
s
a
n
a
ly
si
s
a
n
d
m
e
tm
yo
g
lo
b
in
fo
rm
a
tio
n
S
u
p
p
re
ss
e
d
m
e
tM
B
fo
rm
a
tio
n
a
n
d
H
P
O
a
c
c
u
m
u
la
tio
n
b
y
1
m
L
o
f
e
xt
ra
c
t
(1
0
g
fr
e
sh
m
a
te
ria
lt
o
1
0
0
g
o
f
m
in
c
e
d
tu
n
a
m
e
a
t)
S
h
o
w
e
d
a
n
ti-
d
is
c
o
lo
ra
tio
n
a
c
tiv
ity
w
ith
1
m
L
o
f
e
xt
ra
c
t
(1
0
g
fr
e
sh
m
a
te
ria
lt
o
1
0
0
g
o
f
m
in
c
e
d
tu
n
a
m
e
a
t)
B
a
o
e
t
a
l.,
2
0
1
0
b
(C
o
n
ti
n
u
e
d
)
Frontiers in Pharmacology | www.frontiersin.org 11 December 2016 | Volume 7 | Article 474
Tang et al. Flammulina velutipes
T
A
B
L
E
6
|
C
o
n
ti
n
u
e
d
B
io
a
c
ti
v
it
ie
s
Te
s
te
d
s
u
b
s
ta
n
c
e
E
x
p
e
ri
m
e
n
ta
l
d
e
s
ig
n
D
o
s
a
g
e
a
n
d
re
s
u
lt
s
R
e
fe
re
n
c
e
s
E
th
yl
a
c
e
ta
te
o
f
F.
ve
lu
ti
p
e
s
m
yc
e
liu
m
g
ro
w
n
in
2
%
g
lu
c
o
se
In
vi
tr
o
e
xp
e
rim
e
n
t—
a
n
ti-
ty
ro
si
n
a
se
a
c
tiv
ity
a
ss
a
y
D
e
m
o
n
st
ra
te
d
in
h
ib
ito
ry
a
c
tiv
ity
o
f
5
8
.8
%
a
g
a
in
st
ty
ro
si
n
a
se
a
t
0
.5
m
g
/m
L
o
f
e
xt
ra
c
t
K
im
e
t
a
l.,
2
0
1
1
A
n
tim
ic
ro
b
ia
la
c
tiv
ity
M
e
th
a
n
o
la
n
d
c
h
lo
ro
fo
rm
e
xt
ra
c
ts
o
f
F.
ve
lu
ti
p
e
s
In
vi
tr
o
e
xp
e
rim
e
n
t—
p
la
te
d
iff
u
si
o
n
M
e
th
a
n
o
le
xt
ra
c
t
e
xh
ib
ite
d
st
ro
n
g
e
st
a
n
tib
a
c
te
ria
la
c
tiv
ity
a
g
a
in
st
S
.
a
u
re
u
s
fr
o
m
h
o
rs
e
w
o
u
n
d
in
fe
c
tio
n
w
ith
1
9
.7
5
m
m
zo
n
e
in
h
ib
iti
o
n
C
h
lo
ro
fo
rm
e
xt
ra
c
t
e
xh
ib
ite
d
st
ro
n
g
e
st
a
n
tib
a
c
te
ria
la
c
tiv
ity
a
g
a
in
st
B
a
c
ill
u
s
sp
.
fr
o
m
a
n
im
a
ls
ki
n
w
ith
1
5
.7
5
m
m
zo
n
e
in
h
ib
iti
o
n
K
a
ra
m
a
n
e
t
a
l.,
2
0
1
0
M
e
th
a
n
o
le
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
In
vi
tr
o
e
xp
e
rim
e
n
t—
m
ic
ro
d
ilu
tio
n
m
e
th
o
d
D
is
p
la
ye
d
a
n
tib
a
c
te
ria
la
c
tiv
ity
a
g
a
in
st
B
.
s
u
b
ti
lis
A
T
C
C
6
6
3
3
,
B
.
p
u
m
ilu
s
N
C
T
C
8
2
4
1
,
S
.
a
u
re
u
s
A
T
C
C
6
5
3
8
a
n
d
P.
a
e
ru
g
in
o
s
a
A
T
C
C
9
0
2
7
w
ith
M
IC
m
e
a
su
re
d
a
t
1
2
.5
,
3
.1
2
5
,
5
0
a
n
d
5
0
m
g
/m
L
,
re
sp
e
c
tiv
e
ly
N
e
d
e
lk
o
sk
a
e
t
a
l.,
2
0
1
3
F.
ve
lu
ti
p
e
s
c
o
lo
n
y
In
vi
tr
o
e
xp
e
rim
e
n
t—
d
u
e
lc
u
ltu
re
te
c
h
n
iq
u
e
S
h
o
w
e
d
c
o
m
p
le
te
re
p
la
c
e
m
e
n
t
a
g
a
in
st
O
p
h
io
s
to
m
a
u
lm
i
S
h
o
w
e
d
p
a
rt
ia
lr
e
p
la
c
e
m
e
n
t
a
g
a
in
st
F.
o
xy
s
p
o
ru
m
,
P.
fu
n
e
re
a
l
a
n
d
F.
c
u
lm
ir
u
m
L
M
2
0
9
1
B
o
rh
a
n
ie
t
a
l.,
2
0
1
1
E
n
o
ki
p
o
d
in
A
(3
5
)
E
n
o
ki
p
o
d
in
C
(3
6
)
In
vi
tr
o
e
xp
e
rim
e
n
t—
p
la
te
d
iff
u
si
o
n
a
n
d
b
ro
th
d
ilu
tio
n
E
n
o
ki
p
o
d
in
A
(3
5
)—
a
g
a
in
st
B
.
s
u
b
ti
lis
L
M
A
0
0
1
1
(2
1
–3
0
m
m
),
B
.
s
u
b
ti
lis
IF
O
1
2
7
3
4
(2
1
–3
0
)
m
m
a
n
d
S
.
a
u
re
u
s
A
H
U
1
1
4
2
(1
6
–2
0
m
m
)
a
t
5
0
µ
g
E
n
o
ki
p
o
d
in
A
(3
5
)
sh
o
w
e
d
a
n
tib
a
c
te
ria
la
c
tiv
ity
a
g
a
in
st
B
.
s
u
b
ti
lis
L
M
A
0
0
1
1
w
ith
M
ID
o
f
3
.1
2
µ
g
E
n
o
ki
p
o
d
in
C
(3
6
)—
a
g
a
in
st
B
.
s
u
b
ti
lis
L
M
A
0
0
1
1
(1
6
–2
0
m
m
),
B
.
s
u
b
ti
lis
IF
O
1
2
7
3
4
(1
6
–2
0
m
m
)
a
n
d
S
.
a
u
re
u
s
A
H
U
1
1
4
2
(1
6
–2
0
m
m
)
a
t
5
0
µ
g
E
n
o
ki
p
o
d
in
C
(3
6
)
sh
o
w
e
d
a
n
tib
a
c
te
ria
la
c
tiv
ity
a
g
a
in
st
B
.
s
u
b
ti
lis
L
M
A
0
0
1
1
w
ith
M
ID
o
f
6
.2
5
µ
g
Is
h
ik
a
w
a
e
t
a
l.,
2
0
0
1
,
2
0
0
5
F
la
m
ve
lu
tp
e
n
o
id
A
–D
(3
7
to
4
0
)
In
vi
tr
o
e
xp
e
rim
e
n
t—
b
ro
th
d
ilu
tio
n
D
is
p
la
ye
d
w
e
a
k
a
c
tiv
ity
a
g
a
in
st
E
.
c
o
li,
B
.
s
u
b
ti
lis
a
n
d
m
e
th
ic
ill
in
-r
e
si
st
a
n
t
S
.
a
e
ru
e
s
w
ith
M
IC
o
f
>
1
0
0
µ
M
W
a
n
g
e
t
a
l.,
2
0
1
2
b
E
n
o
ki
p
o
d
in
F
(2
6
)
E
m
o
ki
p
o
d
in
G
(2
7
)
E
n
o
ki
p
o
d
in
I(
2
9
)
E
n
o
ki
p
o
d
in
J
(3
0
)
2
,5
-c
u
p
a
ra
d
ie
n
e
-1
,4
-d
io
n
e
(2
4
)
E
n
o
ki
p
o
d
in
B
(2
2
)
E
n
o
ki
p
o
d
in
D
(2
3
)
In
vi
tr
o
e
xp
e
rim
e
n
t—
m
ic
ro
d
ilu
tio
n
te
c
h
n
iq
u
e
E
n
o
ki
p
o
d
in
s
I(
2
9
),
J
(3
0
),
B
(2
2
),
D
(2
3
)
a
n
d
2
,5
-c
u
p
a
ra
d
ie
n
e
-1
,4
-d
io
n
e
(2
4
)
sh
o
w
e
d
a
c
tiv
ity
a
g
a
in
st
B
.
s
u
b
ti
lis
w
ith
IC
5
0
m
e
a
su
re
d
a
t
1
6
4
.3
,
1
5
1
.2
,
1
4
0
.5
,
1
6
7
.6
a
n
d
1
5
4
.6
,
re
sp
e
c
tiv
e
ly
E
n
o
ki
p
o
d
in
F
(2
6
),
G
(2
7
)
a
n
d
I(
2
9
)
sh
o
w
e
d
a
c
tiv
ity
a
g
a
in
st
A
.
fu
m
ig
a
tu
s
w
ith
IC
5
0
m
e
a
su
re
d
a
t
2
2
9
.1
,
2
3
3
.4
a
n
d
2
3
5
.1
,
re
sp
e
c
tiv
e
ly
W
a
n
g
e
t
a
l.,
2
0
1
2
d
A
n
ti-
in
fla
m
m
a
to
ry
a
c
tiv
ity
F.
ve
lu
ti
p
e
s
in
d
rie
d
p
o
w
d
e
r
fo
rm
In
vi
tr
o
e
xp
e
rim
e
n
t—
G
rie
ss
a
ss
a
y
a
n
d
E
L
IS
A
(T
N
F
-α
)
E
xh
ib
ite
d
N
O
in
h
ib
ito
ry
a
c
tiv
ity
o
f
IC
5
0
a
t
2
4
µ
g
/m
L
E
xh
ib
ite
d
T
N
F
-α
in
h
ib
ito
ry
a
c
tiv
ity
o
f
IC
5
0
a
t
9
9
µ
g
/m
L
G
u
n
a
w
a
rd
e
n
a
e
t
a
l.,
2
0
1
4
W
a
te
r
e
xt
ra
c
t
o
f
F.
ve
lu
ti
p
e
s
In
vi
tr
o
e
xp
e
rim
e
n
t—
N
O
in
h
ib
iti
o
n
a
ss
a
y
a
n
d
W
e
st
e
rn
b
lo
t
In
h
ib
ite
d
N
O
p
ro
d
u
c
tio
n
In
h
ib
ite
d
L
P
S
-i
n
d
u
c
e
d
iN
O
S
a
n
d
C
O
X
-2
e
xp
re
ss
io
n
in
m
a
c
ro
p
h
a
g
e
s
K
a
n
g
,
2
0
1
2
H
e
p
a
to
p
ro
te
c
tiv
e
a
c
tiv
ity
W
a
te
r-
so
lu
b
le
p
o
ly
sa
c
c
h
a
rid
e
o
f
F.
ve
lu
ti
p
e
s
(F
V
P
2
)
In
vi
tr
o
e
xp
e
rim
e
n
t—
vi
a
b
ili
ty
te
st
,
A
LT
a
n
a
ly
si
s
P
ro
m
o
te
d
p
ro
lif
e
ra
tio
n
o
f
p
rim
a
ry
c
u
ltu
re
o
f
m
o
u
se
h
e
p
a
to
c
yt
e
s
a
t
c
o
n
c
e
n
tr
a
tio
n
s
ra
n
g
in
g
fr
o
m
2
5
to
2
0
0
µ
g
/m
L
R
e
d
u
c
e
d
th
e
in
tr
a
c
e
llu
la
r
re
le
a
se
o
f
A
LT
fr
o
m
h
e
p
a
to
c
yt
e
s
in
d
u
c
e
d
b
y
C
C
l 4
in
to
xi
c
a
tio
n
P
a
n
g
e
t
a
l.,
2
0
0
7
Frontiers in Pharmacology | www.frontiersin.org 12 December 2016 | Volume 7 | Article 474
Tang et al. Flammulina velutipes
FIGURE 2 | The graphical abstract of the nutritional values and biological activities of F. velutipes.
HT-29 cells. (Ou et al., 2005; Chung et al., 2010; Jeff et al., 2013).
F. velutipes has also been shown to contain bioactive compounds
with antitumor and anticancer properties (Gu and Leonard, 2006;
Smiderle et al., 2006; Wang et al., 2012b; Yi et al., 2013b).
In 2003, Ikekawa (2001) presented an epidemiological study
spanning 15 years (1972–1986) which showed that the cancer
related death rates of farmers who grew F. velutipesmushroom—
assuming that they would have eaten some of the mushrooms
they farmed—were lower by 39% when compared to comparable
populations not involved in mushroom farming (Monro, 2003).
Experimental evidence also demonstrated that F. velutipes
extract possesses anticancer properties, and several anticancer
compounds have been isolated from F. velutipes in recent
decades. Gu and Leonard (2006), among others, revealed
the anticancer potential of fruiting bodies extract from F.
velutipes, which was particularly effective against breast cancer
cell lines. In the study, F. velutipes extract was shown to
inhibit the growth of both estrogen-receptor positive (ER+)
MCF-7 and estrogen-receptor negative (ER−) MDA-MB-231
human breast cancer cell lines. Furthermore, the extract induced
apoptosis in the breast cancer cells and also caused 99%
inhibition of colony formation of MCF-7 (Gu and Leonard,
2006).
Recently, several novel bioactive compounds with anticancer
activities were isolated from the cultures of F. velutipes. A
research group from China discovered a sesquiterpene with a
novel carbon skeleton, known as flammulinol A (13), together
with sterpuric acid (14), an isolactarane sesquiterpene and six
isolactarane-related norsesquiterpenes (flammulinolides A–G)
(15 to 21) from the solid culture of F. velutipes (Wang et al.,
2012c). These isolactarane-related norsesquiterpenes (15 to 17,
19 to 21) extracted from the solid culture of F. velutipes were
found to possess cytotoxic effect against several cancer cell
lines. Flammulinolide A (15) showed cytotoxic effect against KB
cells (human nasopharyngeal carcinoma) and HepG2 (human
hepatocellular liver carcinoma) with an IC50 of 3.6 and 34.7µM,
respectively, whereas flammulinolide C (17) exhibited strong
cytotoxicity against HeLa cells (human cervical adenocarcinoma)
with an IC50 of 3.0 µM (Wang et al., 2012c). Other groups
have reported the isolation of sesquiterpenes (22 to 30) from
solid culture of F. velutipes grown on cooked rice, sesquiterpenes
(22 to 24, 30) were reported to have moderate cytotoxicity
against human tumor cell lines: HepG2 (liver cancer cells), MCF-
7 (breast cancer cells), SGC7901 (stomach cancer cells), and A549
(lung cancer cells) with IC50 within 20 to 100 µg /mL (Wang
et al., 2012d). A new nonsesquiterpene alkaloid (31) derived from
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fermented rice substrate of F. velutipes was also discovered to
exhibit inhibitory effect against human KB cells in vitro (Xu et al.,
2013).
Aside from the sesquiterpenes, bioactive polysaccharides
from F. velutipes are also potential anticancer agents. The
polysaccharides of F. velutipes demonstrated antitumor and
anticancer properties against sarcoma SC-180 mouse model and
S-180 mice tumor model in vivo and hepatoma SMMC-7721
cells in vitro (Leung et al., 1997; Jiang et al., 1999). Recently,
crude polysaccharide from mycelia of the mushroom was also
found to reduce the proliferation of human BEL-7402 lung cancer
cells by 45% at 640 µg/mL (Zhao et al., 2013). Triple helix
structured polysaccharides extracted by ultrasonic wave from F.
velutipes exhibited high inhibitory effect against BGC-82 gastric
cancer cells, suggesting a potential role in prevention of gastric
carcinoma (Yang et al., 2012). Beta-glucan, which is well known
for its antitumor activity (Zhang et al., 2007; Mantovani et al.,
2008), was also isolated from F. velutipes (Smiderle et al., 2006).
Sterols extracted from F. velutipes, consisting of mainly
ergosterol (32) (54.8%) and 22, 23-dihydroergosterol (33)
(27.9%), were found to be potential therapeutic agents against
stomach, liver, lung cancer and gliomas. It showed potent
antiproliferative activity against human SGC cells (stomach
cancer cells) with an IC50 of 11.99 µg/mL, HepG-2 cells with
IC50 at 9.3 µg/mL, A549 lung cancer cell with IC50 at 20.4
µg/mL and U251 glioblastoma with IC50 at 23.42 µg/mL (Yi
et al., 2012, 2013a,b). Studies have also been done to improve
the bioavailability, biodistribution and solubility of sterols from
F. velutipes through encapsulation in liposomes, mixed micelles
nanoformulation and microemulsion (Yi et al., 2012, 2013a,b).
F. velutipes extract was found to contain phenolic compounds
such as protocatechuic acid (1), p-coumaric (2), and ellagic acid
(3) (Rahman et al., 2015) which have anticancer effects (Ferguson
et al., 2005; Seeram et al., 2005). Both p-coumaric (2) and ellagic
acid (3) have potent antioxidative effect on human colon cells,
HT-29 and HCT 16 cell lines, respectively (Ferguson et al.,
2005; Seeram et al., 2005). Ellagic acid was shown to be able to
reduce hepatic P450 level and also its catalytic activities in vitro,
thus decreasing the metabolism of carcinogens that can cause
chemically induced cancer (Ahn et al., 1996).
The biological activities of FIP-fve, a bioactive protein isolated
from the mushroom F. velutipes, have also been investigated
extensively. FIP-fve belongs to a fungal immunomodulatory
protein (FIP) family that modulates immune responses,
including antitumor activity (Chang et al., 2013). Chang et al.
(2010) suggested that FIP-fve is able to reduce the expression
of RACGAP1 gene and also reduce its reporter activity (Chang
et al., 2013). The RACGAP1 gene is responsible for the survival
and metastatic activity of lung cancer cells, thus, silencing of
this gene reduces the migration of cancer cells (Wang et al.,
2011). Besides that, FIP-fve also increased tumor suppressor
gene p53 expression and also its downstream gene, p21, thus
attenuating the proliferation of A549 lung cancer cells (Chang
et al., 2013). In another study, Chang et al. (2010) demonstrated
that the oral administration of FIP-fve reduced the tumor
size of BNL hepatoma-bearing mice and suggested that the
antitumor effect was mediated by IFN-γ-induced tumor growth
inhibition effect involving both innate and specific immunity and
ERK/MAPK signaling pathway. The study also showed that the
antitumor effect of FIP-fve was mediated through the inhibition
of angiogenesis by CD4+ T-cell-derived IFN-γ. In addition, the
study showed that the expression of MHC class I and II and co-
stimulatory molecule CD80 on peripheral blood mononuclear
cell was also increased, suggesting the oral administration of FIP-
fve exerted antitumor effect through upregulation of presenting
ability of APCs (Chang et al., 2010). These findings are in
concordance with another in vivo study whereby FIP-fve protein
activated the maturation of splenic dendritic cells, an APC and
stimulated antigen-specific CD8+ T-cell immune responses.
Administration of FIP-fve as adjuvant therapy along with
HPV-16 E7 vaccine to tumor bearing mice resulted in increased
production of HPV-16 E7-specific antibodies and increased
expansion of HPV-16 E7-specific interferon (IFN)-γ-producing
CD4+ and CD8+ T cells compared with HPV-16 E7 vaccine
alone, resulting prolonged lifespan of the mice (Ding et al.,
2009). Overall, the evidence is strongly suggestive that FIP-fve
is a potential agent for the development of novel adjuvants for
cancer immunotherapy.
Glycoproteins found in the fruiting body and mycelium
of F. velutipes also exhibit anticancer effect (Zhang et al.,
2007). Proflamin, an acidic glycoprotein isolated from the
mycelium enhanced several immunosuppression processes and
exhibited antiproliferative effects against various cancer cells. It
was demonstrated to be able to prolong the lifespan of mice
bearing B-16 melanoma and adenocarcinoma 755 tumor cells
(Ikekawa et al., 1985). When given as combination therapy
along with vaccines or surgery, it also inhibited the growth
of sarcoma S-180, L1210 leukemia ascite cells and Meth-A
fibrosarcoma. The study also revealed another protein-bound
polysaccharide, EA6 significantly inhibited the proliferation of
Meth-A fibrosarcoma. Similar to FIP-fve, the antitumor effects of
EA6 which are manifested by virtue of strengthening the specific
and innate immunity, were shown to be mediated by CD4+
T cells (Maruyama and Ikekawa, 2007). To date, it is obvious
that many bioactive compounds with effective anticancer and
antitumor properties have been isolated from different parts of
F. velutipes, indicating that this mushroom is a good source for
future development of chemotherapeutic agents. Nevertheless,
studies are still required to further study the bioavailability of
these bioactive compounds derived from F. velutipes and also
their exact mechanisms of action.
Vascular Diseases: Anti-Atherosclerotic
and Thrombosis Inhibition
Oxidized low density lipoprotein (ox-LDL) has long been known
to be the key player in the early events of the atherosclerosis
cascade. Lipid hydroperoxides are formed when polyunsaturated
fatty acid is oxidized by free radicals, and the continuous
oxidation and reduction of the hydroperoxides will further
augment the peroxidation process. Recently, Rahman et al.
(2015) demonstrated the polyphenolic compounds present in
methanol:dichloromethane (M:DCM) fraction of F. velutipes are
able to retard LDL oxidation, thus possibly being effective in
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impeding the progression of atherosclerosis. Protocatechuic acid
(1), p-coumaric (2) and ellagic acid (3) were identified from
the M:DCM fraction of F. velutipes that showed the longest lag
time of conjugated diene formation and inhibition of TBARS
formation (Rahman et al., 2015). The study suggested that the
inhibition of the peroxidation processes may be attributed to the
chain breaking actions of the phenolic compounds which are
able to reduce the alkoxyl or peroxyl radicals to alkoxides or
hydroperoxides, respectively, interfering with the peroxidation
process (Rice-Evans et al., 1997). In addition, the study also
proposed that the antiatherosclerotic effect demonstrated by
the M:DCM fraction of F. velutipes may be mediated through
anti-inflammatory effects. Protocatechuic acid (1) is known to
prevent the adhesion of monocytes to tumor necrosis factor-
alpha(TNF-α)activated endothelial cells, leading to a reduction
of the expression of vascular cell adhesion molecule 1 (VCAM-
1), intercellular adhesion molecule 1 (ICAM-1) and also nuclear
factor kappa-light-chain-enhancer of activated B cells (NF-
κB) binding activity, thus reducing the formation of atheroma
(Kakkar and Bais, 2014). Another phenolic constituent of the
fraction, p-coumaric acid (2) is able to inhibit ADP-induced
platelet aggregation, interrupt the arachidonic acid cascade
and decrease thromboxane B2 and lipopolysaccharide-induced
prostaglandin E2 production, hence inhibiting the formation
of plaque and inflammation process (Luceri et al., 2007). In
conclusion, the phenolic components in F. velutipes, which have
high ability toward withstanding the oxidation of LDL as well as
their anti-inflammatory activity, may be the agents contributing
to the overall anti-atherosclerotic properties of the extract.
Thrombosis is one of the important initial events that takes
place during accelerated atherosclerosis (Walters et al., 1994).
One study revealed that the use of F. velutipes in fermentation
may produce fermented products which possess preventive
activity against thrombosis. It has been demonstrated that the
addition of F. velutipes in fermentation process resulted in end-
product with a prolonged thrombin clotting time (358.6 ± 0.4
sec) of 2.2-fold than that of the control. Further experimentation
has also demonstrated a strong fibrinolytic activity on a fibrin
plate (Okamura et al., 2001). A more recent study successfully
purified and characterized a fibrinolytic enzyme from the culture
supernatant of F. velutipes mycelium (Park et al., 2007). The
fibrinolytic enzyme (FVP-I), a protease from F. velutipes was
shown to be a direct-acting fibrinolytic and fibrinogenolytic
agent which elicits direct cleavage of fibrin and fibrinogen
without the need of plasminogen activator, thus demonstrating
potential as thrombolytic therapy (Park et al., 2007). Collectively,
the evidence suggests that F. velutipes is a potential source of
bioactive substances for drug development in vascular disease
prevention.
Antihypertensive and
Cholesterol-Lowering Effect
Almost 17 million deaths, approximately 1/3 of the total deaths
in a year are due to cardiovascular diseases; and among these,
complications of hypertension account for approximately 9.4
million deaths. Hypertension, together with other health risk
factors, is associated with highly detrimental complications
including increased probability of heart attack, stroke and
kidney disease as well as other chronic diseases. These risk
factors include tobacco use, diabetes and hypercholesterolemia
(World Health Organization, 2013). The consumption of herbs
and mushrooms as dietary supplement has been known to be
beneficial to people with cardiovascular diseases (Tan et al.,
2016c). Owing to the rich content of dietary fiber, mushrooms
can help in cholesterol metabolism and absorption, thereby
lowering the risk of cardiovascular diseases. There is also
a growing interest in F. velutipes as an attractive source of
various biologically active components including dietary fiber,
polysaccharides and mycosterol that have been long known to
possess cholesterol and blood pressure lowering effects (Yeh et al.,
2014). In fact, F. velutipes was shown to contain the highest fiber
content as compared to other mushrooms such as L. edodes,
oyster cap fungi and cap fungi (Yang et al., 2001).
Yeh et al. (2014) investigated the effect of the active
components of both F. velutipes powder and F. velutipes extract
on the lipid metabolism of male hamsters on a high fat diet. The
study revealed that both F. velutipes extract and powder at dose of
3% are capable of reducing the level of TC (total cholesterol), TG
(triacylglycerol), LDL (low density lipoprotein cholesterol), and
LDL/HDL (high density lipoprotein cholesterol) in the serum
and liver of the hamsters significantly (Yeh et al., 2014). This
is in agreement with the findings of another study whereby
the exo-polymer of F. velutipes exerted hypolipidemic effect
on diet-induced hyperlipidemic rats. Significant reduction in
plasma triglyceride, plasma TC, LDL and liver TC levels were
observed from the animals administered F. velutipes exo-polymer
at 100g/kg body weight for 4 weeks (Yang et al., 2002). It was also
demonstrated that the F. velutipes fiber diet resulted in reduction
of plasma TC and increased fecal cholesterol excretion and liver
LDL receptor mRNA level in rats (Fukushima et al., 2001).
Mushrooms are known to elicit hypocholesterolemia and
also to possess anti-hypertensive properties. Chen et al.
(2012) reported the detection of both lovastatin (12) and γ-
aminobutyric acid (GABA) in the fruiting body of F. velutipes.
Lovastatin (12) is used clinically for its inhibitory effect on
cholesterol production, thereby reducing the risk of coronary
heart disease. Many studies have shown that food products
containing GABA are able to lower the blood pressure of
hypertensive subjects (Aoki et al., 2003; Inoue et al., 2003;
Hayakawa et al., 2004). Another study reported that the
administration of GABA enriched F. velutipes powder (0.9mg
GABA /kg) was successful in reducing the systolic blood pressure
by 30mmHg in spontaneously hypertensive rats. Of particular
note, the study also reported that those with normal blood
pressure were not affected by the powder (Harada et al., 2011).
These results were suggested to be due to GABA’s effects on
inhibiting noradrenaline release from the sympathetic nervous
system, ameliorating the rise in blood pressure (Hayakawa et al.,
2002).
Furthermore, an optimized culture broth used for the growth
of F. velutipes mycelium was shown to display prominent
inhibition of angiotensin converting enzyme with IC50 of
22.6mg/mL (Kim et al., 2002). The authors also highlighted that
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the use of the culture broth of F. velutipes as a source for ACE
inhibitor provides many benefits for the future development of
anti-hypertensive agents that are important for the treatment for
cardiovascular diseases (Kim et al., 2002).
Memory and Learning Improvement
Alzheimer’s disease is a progressive neurodegenerative disorder
characterized by the deterioration of cognition and memory.
Studies have indicated that loss of basal forebrain cholinergic
neurons involved in learning and memory processes constitutes
a pathological hallmark of Alzheimer’s disease (Martorana et al.,
2010). Besides the cholinergic hypothesis, neurodegenerative
disease, including Alzheimer’s disease, are also associated with
oxidative damage in the brain resulting from an imbalance
between reactive oxygen species generation and antioxidant
enzyme activity (Wong et al., 2012; Sayyad et al., 2016; Ser
et al., 2016). Previous reports revealed that several mushrooms
have been demonstrated to exhibit cognitive enhancing activity
including Hericium erinaceus (Yamabushitake) (Mori et al.,
2009), Inonotus obliquus (Chaga) (Giridharan et al., 2011) and
Cordyceps militaris (Tsai et al., 2015). Several recent studies have
also sought to investigate the beneficial effects of F. velutipes in
cognitive function improvement (Yang et al., 2011, 2015).
An in vivo study showed that polysaccharides from F. velutipes
(FVP) were effective against the progression of scopolamine
induced learning and memory deficits in rats (Yang et al.,
2015). The study revealed that the administration of FVP
prevented the reduction of the antioxidant defense enzymes
activities and elevation of TBARS levels caused by scopolamine
in the rats, showing that FVP improved the memory deficits
in the rats through amelioration of oxidative stress (Gao
et al., 2012; Yang et al., 2015). FVP was also found to restore
the level of the neurotransmitter acetylcholine (ACh) in the
hippocampus and cerebral cortex by modulating the activities
of its synthetic enzyme, choline acetyltransferase (ChAT) and
its hydrolysing enzyme, acetylcholinesterase (AChE). It also
normalized the levels of other neurotransmitters including the
serotonin, dopamine, and norepinephrine, thereby reversing the
effect of scopolamine on the reduction of the neurotransmitters
(Yang et al., 2015). These neurotransmitters are known to be
involved in both memory and learning functions (Wang et al.,
2013). In addition, FVP was also shown to prevent learning
and memory impairment by regulating the expression of protein
kinases, CaMK II and connexin 36 which plays a role in the
synthesis and secretion of neurotransmitters (Yang et al., 2015).
Another study also demonstrated that the FVP extracted using
ultrasonic methods displayed AChE inhibitory rate of 18.51%
at 0.6mg/ml, suggesting FVP has potential in improvement of
learning and cognitive ability (Yang et al., 2011).
Ribosome Inactivating Protein
Ribosome inactivating protein (RIP) is well known for exhibiting
diverse bioactivities including antitumour, immunomodulatory,
abortifacient, and anti-human immunodeficiency (anti –HIV)
virus actions (Ng et al., 1992). Wang and Ng (2001) isolated an
RIP designated as velutin from F. velutipes.Velutin was shown to
possess N-terminal sequence which resembles most other plant
RIPs to a certain extent, however, its 10kDA molecular weight is
much lower compared to the others, which mostly range from
25 to 30 kDA (Ng et al., 1992; Wang and Ng, 2001). Velutin was
reported to inhibit the activity of HIV virus reverse transcriptase
and also glycohydrolase, mainly α- and β-glucosidases which
play a part in HIV infection (Wang and Ng, 2001). Besides that,
velutin was also non-teratogenic when tested on mouse embryos
(Ng et al., 2010).
Flammin and velin were the other two RIPs discovered from
F. velutipes (Ng and Wang, 2004). Both of these RIPs do not
show much resemblance in terms of N-terminal sequence to the
published mushrooms RIPs, instead they show more similarities
with angiosperm RIPs. Flammin and velin do not exhibit
any RNase and protease activities. This lack of ribonuclease
activity further confirms that the cell free translation-inhibitory
activity is attributed to ribosome inactivation and not the
result of hydrolysis of RNA and protein (Ng and Wang, 2004).
Flammulina was another RIP found in the mushroom, and
similar to flammin and velin, this protein is also found to be
devoid of ribonuclease activity (Wang and Ng, 2000).
Antioxidant Activities
Reactive oxygen species (ROS) refers to free radicals derived
from oxygen, including superoxide anion, nitric oxide, hydroxyl
radical and hydroxyl peroxide. ROS have important functions
such as signaling and regulating the fundamental cellular
processes of development such as cell death, oogenesis,
spermatogenesis, angiogenesis and redox regulation of cells
(Chan et al., 2015). However, excessive accumulation of ROS
leads to conditions of oxidative stress which causes damage to
lipid, DNA and protein, resulting in detrimental effects to the
body (Covarrubias et al., 2008). Antioxidants are substances
which can delay, prevent or reverse oxidative damage and are
known to prevent several chronic diseases such as cancer and
diabetes (Karaman et al., 2010; Lau et al., 2015). Butylated
hydroxyanisole and butylated hydroxytoluene are examples of
potent synthetic antioxidants, however, some of them are found
to be toxic and carcinogenic to human body, thus efforts
are now focusing on discovering natural antioxidant products
(Moghadamtousi et al., 2014; Ma et al., 2015b; Tan et al.,
2015a; Ser et al., 2016). Due to its various biological activities
including the antioxidant properties, F. velutipes, as one of the
most popular edible mushrooms, has attracted a considerable
amount of attention in different fields including biochemistry
and pharmacology (He and Zhang, 2013).
Over the years, many studies have reported that carbohydrate
content, mainly the polysaccharides of F. velutipes exhibit
antioxidant activity (Ma et al., 2015b; Xia, 2015). In recent
decades, studies have reported high antioxidant activities
shown by the different carbohydrate products derived from
F. velutipes by using various extraction methods. Ma et al.
(2015b) investigated the antioxidant capacity of the intracellular
polysaccharides (IPS) extracted from F. velutipes mycelia. The
study indicated rhamnose was the major component in IPS
responsible for the strong antioxidant activity in vitro including
the ability to scavenge hydroxyl and DPPH radicals (Ma et al.,
2015b). Besides, the study also showed IPS exhibited anti-aging
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potential in which the anti-aging enzyme, superoxide dismutase
(SOD) in the blood, heart and kidney was increased following
treatment with increasing concentrations of IPS (Ma et al.,
2015b). SOD protects cells from being damaged by superoxide
anion radicals by converting them to hydrogen peroxide, a
less active free radical (Siu et al., 2013). In another study,
exopolysaccharides (EPS) from F. velutipes were purified and
characterized and it was found that the purified fractions were
mainly composed of rhamnose (Ma et al., 2015a). Similarly, these
EPS fractions were shown to exhibit potent antioxidant activity
in vitro such as reducing power and the scavenging capability of
hydroxyl, DPPH and superoxide anions (Ma et al., 2015a). This
study also demonstrated the purified EPS fractions stimulated
anti-aging activity in mice as evidenced by the increased catalase
level and decreased malondialdehye content in the organs of the
mice. At 800 mg/kg weight, which was the highest dosage of EPS
used in the experiment, catalase activity was the highest in heart
with 10.12± 0.05 U/mg protein. At 800 mg/kg dosage of EPS, the
MDA content was the least in liver, 0.62± 0.03 nmol/mg protein
which is 110% lower than the model control group treated with
saline and d-galactose.
Oligosaccharides derived from F. velutipes by hydrolysis
using hydrogen peroxide also showed a strong hydroxyl radical
scavenging of 80.24% at the concentration of 100 µg/mL (Xia,
2015). Wu et al. (2014) extracted polysaccharide, FVP 1-A
from F. velutipes, which exhibited superoxide radical scavenging
ability with an IC50 value of about 10 mg/mL, hydroxyl radical
scavenging ability with an IC50 value of about 12 mg/mL and
reducing power of 1.04, showing a high antioxidant capacity. At
200 µg/mL, polysaccharide from liquid culture mycelia extracted
using double distilled water, displayed DPPH scavenging rate of
65.85% and hydroxyl radical scavenging rate of 71.24% (Zhao
et al., 2013).
Variation in extraction methods may also influence the
antioxidant properties of the polysaccharides derived from F.
velutipes. A study showed that the polysaccharides of F. velutipes
extracted using various extraction methods (conventional
solvent extraction, ultrasound-assisted extraction (UAE),
microwave-assisted extraction (MAE), enzymatic aqueous
extraction (EAE)) were found to exhibit differential antioxidant
activities in different in vitro assays. Crude polysaccharides
(CFP) demonstrated the highest antioxidant activity in terms
of reducing power, EAE polysaccharides (EFP) had the highest
hydroxyl radical scavenging andmetal chelating activity, whereas
UAE polysaccharides (UFP) had the highest DPPH scavenging
activity. The researchers deduced that the molecular weight
and chemical structure of the polysaccharides obtained from
different extraction methods played a role in determining their
antioxidant properties (Zhang et al., 2013). UFP and MFP
exhibited very much greater DPPH scavenging ability compared
to EFP and CFP; the high antioxidant capacity observed may
be due to the further alteration of chemical structures and
decomposition of polysaccharides caused by the ultrasonic and
microwave treatments (Yang et al., 2008).
Aside from polysaccharides, the phenolic compounds are
also major naturally occurring antioxidant compounds in
mushrooms (Barros et al., 2007; Kim et al., 2008). The total
phenolic content in the mushrooms has a positive correlation
with its antioxidant property measured by in vitro assays such
as DPPH assay, hydroxyl assay and lipid peroxidation assay
(Karaman et al., 2010). Zeng et al. (2012) demonstrated that
F. velutipes possesses the highest phenolic content based on
it having the highest antioxidant activities in terms of ferric
reducing antioxidant power and ferrous ion chelating activity
among three other Australian mushrooms. In contrast, Karaman
et al. (2009) found that F. velutipes has poorer phenolic
content compared to other lignicolous fungi, suggesting that
the prominent antioxidant activity may due to other secondary
biomolecules which had yet to be identified at the time of
the study. Besides the fruiting body of F. velutipes, the spent
culture medium of the mushroom was also shown to contain
high amount of phenolic acids and show potent antioxidative
action against lipid oxidation, demonstrating its role as a
potential antioxidative agent (Bao et al., 2010a). For instance,
p-coumaric acid (2), one of the hydroxycinnamic acids found
in the mushroom, was shown to increase the activity of SOD
and inhibited oxidative stress, resulting in reduction of cardiac
apoptosis in isoprenol-induced myocardial infarction in rats
(Stanely Mainzen Prince and Roy, 2013). Ellagic acid (3), which
was detected in the fruiting bodies of F. velutipes, and is also
present in other fruits and nuts such as pomegranate and walnuts,
was shown to be a potent antioxidant exhibiting DPPH radical
and hydroxyl radical scavenging, reducing capacity and metal
chelating activities (Kilic et al., 2014).
Besides phenols and carbohydrates, a few other bioactive
compounds present in F. velutipes were shown to exhibit
antioxidant activity. Nucleotides derived from F. velutipes were
reported to possess mild antioxidant activity. They showed
reducing power value of 0.5 at 40 mg/mL and ABTS radical
scavenging ability of 60% at 50 mg/mL (Cheng et al., 2012).
F. velutipes was reported to contain 46 mg/100g dry matter of
vitamin C which is a well-known antioxidant (Breene, 1990; Fu
et al., 2002). Sesquiterpenes (22 to 24, 30) extracted from solid
culture F. velutipes grown on cooked rice were demonstrated to
have DPPH radical scavenging ability (Wang et al., 2012d).
Recently, a study investigated the effect of selenium on the
antioxidant activity of F. velutipes (Milovanovic et al., 2015).
Selenium participates in the process of selenoproteins and
selenoenzyme synthesis which work to protect cells from free
radicals. The study demonstrated that selenium supplemented
mycelium had enhanced total phenol content and also enhanced
DPPH radicals scavenging ability of the mushroom extract
(Milovanovic et al., 2015).
Interestingly, a study conducted by Zhang et al. (2013)
demonstrated that the different varieties of F. velutipes possess
different degrees of antioxidant activities. The investigation
included four F. velutipes varieties: Fxuexiu (snowy white),
FD (off-white), F3415 (yellow) and FYehuang (snuff color).
Fxuexiu and F3415 had higher total phenolic and ergothioneine
(34) (ESH) content compared to the other two. In term of
their antioxidant activities, F3415 exhibited the strongest DPPH
radical scavenging ability and metal chelating ability, Fxuexiu
showed the greatest reducing capability and FD had the most
potent hydroxyl radical scavenging ability. Meanwhile, Fyehuang
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displayed the weakest antioxidant activity among the three other
varieties (Zhang et al., 2013). A linear relationship was observed
between the phenolic acid and ESH content of the samples
and their DPPH radical scavenging ability and reducing power.
These findings were concordant with those of Bao et al. (2009)
which stated that high DPPH radical scavenging activity of the
mushroom was mainly attributed to its ESH content (Bao et al.,
2009; Zhang et al., 2013). Furthermore, greater ESH level was
associated with a stronger delay in autoxidation of oxymyoglobin
(Bao et al., 2010a; Chen et al., 2012).
Based on these studies, it can be concluded that the
strong antioxidant activity of F. velutipes is attributed to its
various bioactive components, namely polysaccharides, phenols,
rhamnose sugar, ESH, vitamin C and nucleotides. Different parts
of F. velutipes including fruiting body, mycelium and even its
spent culture medium are sources of potential antioxidants.
Different extraction methods of polysaccharides yield extracts
with varying antioxidant properties. Antioxidant ability of the
mushroom extract also can be increased with the addition of
selenium in the medium. Lastly, antioxidant capacity of F.
velutipes varies between different varieties.
Immunomodulatory Properties:
Anti-Allergy, Anti-Viral and
Anti-Complement Activity
Recently, many studies have been done on medicinal plants in
search of compounds that exhibit immunomodulatory properties
as it has been discovered that the modulation of the immune
system helps to prevent diseases. The currently available chemical
drugs used as immunomodulators have shown to possess a higher
risk profile when compared to natural immunomodulators (El
Enshasy and Hatti-Kaul, 2013; Shukla et al., 2014). Mushrooms
have been known for their medicinal value for decades, and
many of the compounds extracted from mushrooms have
been demonstrated to have modulatory effects on the immune
system (Lee et al., 2011). F. velutipes is one of the medicinal
mushrooms that exhibits immunomodulatory activities. Fungal
Immunomodulating Protein (FIP) is one of the main compounds
exhibiting immunomodulatory properties in F. velutipes. There
was also evidence in a recombinant study expressing the
recombinant FIP-fve cloned in the expression cassette vector
pQE-30 in E. coli M15. The recombinant FIP-fve was shown
to modulate different cytokine gene expression in mouse spleen
cells, including the increased expression of IL-2, IL-4, IFN-γ,
TNF-α, LT, and IL-2R (Li et al., 2011).
One of the earliest studies showed that oral administration
of FIP extracted from F. velutipes (FIP-fve) induced Th-1
predominant allergen-specific immune response and protected
the mice from anaphylaxis-like symptoms induced by oral
challenge with ovalbumin (OVA) (Hsieh et al., 2003). Therefore,
Hsieh et al. (2003) proposed that FIP-fve can be developed
as an immunoprophylactic agent against allergic diseases,
showing potential to be used clinically in children for food
allergy prevention. In the following year, it was found that
FIP-fve exerted mitogenic effect on human peripheral blood
lymphocytes, acting as a potent activator for lymphocyte
proliferation (Wang et al., 2004). The study demonstrated
that the activated lymphocytes showed enhanced secretion of
interferon-γ (IFN-γ) associated with ICAM-1 expression, both
in vitro and in vivo. Furthermore, the study showed that the
expression of IFN-γ in Th1 cells was regulated by p38 MAP
kinase pathway in response to FIP-fve (Wang et al., 2004). In
addition, Ou et al. (2009) revealed the IFN-γ production induced
by FIP-fve in human peripheral mononuclear cells was also
mediated by the Ca2+ release and PKC-α activation.
These findings were then followed by several studies
investigating the anti-allergic effect of FIP-fve against allergen-
induced airway diseases (Hsieh et al., 2007; Lee et al., 2013). Hsieh
et al. (2007) investigated the effect of FIP-fve on the survival of
eosinophils isolated and purified from allergic asthmatic patients
in the presence of IL-5. The study indicated that FIP-fve induced
apoptosis of eosinophils in the presence of IL-5 (which is a
survival factor of eosinophils), thereby preventing eosinophils
from undergoing necrosis. Eosinophils are known to be related to
allergic diseases, and apoptosis of eosinophils, without the release
of their contents, is an important feature in the resolution of
inflammation. Furthermore, the study further clarified that the
inhibition of the IL-5-mediated survival of eosinophils by FIP-
fve was mediated through the upregulation of CD95 expression
and the downregulation of BcL-xL and pro-caspase 3 expression
(Hsieh et al., 2007). Lee et al. (2013) conducted an in vivo
study that utilized an OVA-induced chronic airway inflammation
murine model to evaluate the effect of FIP-fve against allergic
airway diseases. The study indicated that both pre-treatment
and post-treatment with FIP-fve successfully suppressed airway
inflammation and hyperresponsiveness. FIP-fve was shown to
inhibit inflammatory cell infiltration and Th2 cytokines, further
strengthening the view that FIP-fve possesses potential as a
therapeutic agent for allergy related diseases (Lee et al., 2013).
Recent studies also demonstrated the anti-allergic effect of FIP-
fve against different allergen-induced airway inflammation in
mice (Chang et al., 2015; Chu et al., 2015). Chu et al. (2015)
showed oral administration of FIP-fve inhibited house dust
mite (HDM)-induced asthma inflammation in mouse model
via the modulation of Th1 cytokine production. Meanwhile,
Chang et al. (2015) showed that intranasal application of
FIP-fve reduced Dermatophagoides microceras (DM)-induced
airway hyper-responsiveness, airway inflammation and cytokine
expression in mice.
Aside from the immunomodulatory properties against allergic
diseases, Chang et al. (2014) showed that FIP-fve can be
potentially used for viral prevention and therapy. The study
revealed that FIP-fve suppressed airway hyperresponsiveness and
inflammation as the result of the downregulated IL-6 expression
in mice infected by respiratory syncytial virus. Chang et al.
(2014) also indicated that pre-treatment of FIP-fve did not
prevent RSV infection but inhibited the replication of RSV
through reduction in NF-κB translocation and increased IFN-γ
expression.
Furthermore, FIP-fve was shown to have the potential to serve
as a novel therapeutic protective agent in preventing adverse
effects of certain drugs (Ou et al., 2015). This study demonstrated
that FIP-fve reversed several side effects of docetaxel—an
Frontiers in Pharmacology | www.frontiersin.org 18 December 2016 | Volume 7 | Article 474
Tang et al. Flammulina velutipes
anticancer drug—against non-small cell lung cancer, without
affecting the potency of docetaxel (Ou et al., 2015). FIP-fve
was shown to significantly reduce the adverse effects caused
by docetaxel with fewer empty vacuoles in bone marrow, less
small intestinal mucosa damage and decreased reduction of
white blood cell counts in mice. Therefore, the study indicated
that FIP-fve showed protective effects against docetaxel-induced
bone and intestinal damages and also enhanced WBC counts
via induction of G-CSF and IL-20 gene expressions (Ou et al.,
2015).
Apart from fungal immunomodulating protein, the
polysaccharides extracted from F. velutipes are also known
to exhibit immunomodulatory properties. Yin et al. (2010)
isolated polysaccharides from F. velutipes mycelium which were
shown to increase nitric oxide (NO) production, IL-1 production
and TNF-α production from macrophages in a dose-dependent
manner. Another study showed that polysaccharides from F.
velutipesmycorrhizae (PFVM) increased the body weight of mice
and the weight ratio of the thymus and spleen (Yan et al., 2014).
According to the study, the T cell subpopulation of thymocytes
and splenocytes were modulated by the administration of
PFVM; CD3+, CD4+ and CD4+/CD8+ counts were increased
while CD8+ counts decreased in a dose dependent manner.
Increasing dosage of PFVM resulted in increased levels of IL-2
and TNF-α. However, IL-2 levels were highest when a medium
dose was administered while TNF-α was found to be highest
when a high dose was administered. A separate study revealed
that a water-soluble polysaccharide from F. velutipes (FVP l-A)
resulted in increased NO and TNF-α production. IL-1β and IL-6
were also increased and lymphocyte proliferation was promoted
(Wu et al., 2014). Similarly, the water extract of F. velutipes
was also demonstrated to enhance splenocyte proliferation and
Th1 cytokine production in mice (Ryu et al., 2014). Another
interesting study by Lee et al. (2011) showed that the boiling
water mushroom F. velutipes extract potentiated the production
of IFNγ and cytotoxic activity against YAC-1 (lymphoma cell) of
large intestinal lamina propria leukocytes but not small intestinal
lamina propria leukocytes (Lee et al., 2011).
The human complement system also participates in the
host defense system in both innate and adaptive immunity
to protect the body from foreign invading agents such as
bacteria, fungi and viruses (Carroll, 2004). Activation of the
complement system can initiate a series of processes including
opsonisation/phagocytosis, release of inflammatory mediators
and the formation of the membrane attack complex, which
subsequently leads to cell lysis. Under the normal physiological
state, the effects of the complement system activation are
beneficial to the host, but the excessive activation of the system
may cause undesirable adverse effects which then contribute
to the pathogenesis of autoimmune and inflammatory diseases.
Therefore, the modulation of complement activity can be an
important and useful tool in the effort to treat inflammatory
diseases such as rheumatism and arthritis. Shin et al. (2007)
investigated the anti-complement activity of seven different
basidiomycetes extracts. The investigation revealed that both the
hot water extracts and ethanol soluble fractions of F. veluitipes
had the strongest anti-complement activity among the tested
basidiomycetes extracts, with IC50 of inhibitory activity toward
total hemolytic complement at 47.1% and 57.5%, respectively.
Antimelanosis, Anti-Discoloration and
Anti-Browning Properties
There has been increased interest directed toward natural
products with melanosis inhibiting properties because post-
harvest melanosis occurring in seafood like crabs and shrimps
reduces the potential value of the seafood thus affecting the
economy (Encarnacion et al., 2011b). In addition, this work also
has potential for developing natural whitening cosmetic products
or natural food anti-browning product (Kim et al., 2011). Several
experiments showed that ergothioneine (34) isolated from F.
velutipes extract decreased polyphenoloxidase (PPO) activity
which causes melanosis in different species of shrimps and crabs
in a dose-dependent manner (Encarnacion et al., 2010, 2011a,b,
2012). Those studies also showed reduction in expression of
prophenoloxidase (proPO) gene in the hemocytes of shrimps
and crabs which had been submerged in ergothioneine-
rich mushroom extract. Furthermore, the melanosis inhibition
activity of the ergothioneine (34) from mushrooms was also
demonstrated by the absence or reduction in blackening of the
carapace of the treated shrimps and crabs compared to the
untreated group. Encarnacion et al. (2012) also suggested that
ergothioneine (34) may be a non-competitive inhibitor which
possibly interacts directly with Cu2+ at the putative binding sites
of polyphenol oxidase enzyme.
The extracts of several mushrooms containing ergothioneine
(34) were also shown to prevent brown discoloration in
processed fish meat (Bao et al., 2010b). Brown discoloration
occurs when both deoxymyoglobin and oxymyoglobin are
oxidized into metmyoglobin (metMb). The study suggested that
F. velutipes extract is able to suppress the formation of metMB.
Moreover, tyrosinase activity, which is involved in the production
of melanin, was shown to be inhibited by ethyl acetate extract
of F. velutipes mycelia grown in a specific medium containing
2% glucose (Kim et al., 2011). These studies have demonstrated
the potential application of F. velutipes extract as an effective
natural alternative to synthetic antimelanosis, anti-discoloration
and anti-browning agents for the food industry.
Antimicrobial Properties: Antibacterial and
Antifungal Activities
Antimicrobial resistance is a significant global public health
concern, particularly the emergence of multi-drugs resistant
strains of pathogens which have developed resistance toward
almost all the available antibiotics (Letchumanan et al., 2015a,b;
Tan et al., 2016d). As a result, there is an increasing push
to search for bioactive compounds from natural sources to
serve as alternative antimicrobials (Tan et al., 2015b, 2016a;
Azman et al., 2016; Chan et al., 2016) Reports on the
occurrence of antimicrobials in F. velutipes mushroom are also
well documented. The antimicrobial activities of extracts from
different parts of F. velutipes have been the focus of several
studies. Karaman et al. (2010) showed that both methanol
and chloroform extracts from mature fruiting bodies of F.
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velutipes exhibited strong antibacterial activities, particularly
against Staphylococcus aureus and Bacillus subtilis. Similarly,
the methanol extract of Macedonian wild F. velutipes fruiting
body was demonstrated to show antibacterial activity against
both Gram-positive and Gram-negative bacteria, including B.
subtilis, Bacillus pumilus, S. aureus, and Pseudomonas aeruginosa
(Nedelkoska et al., 2013). Besides that, the antagonistic activity
of F. velutipes against plant pathogenic fungi was also examined
by evaluating the competitive interactions of the mushroom and
the pathogens in a dual culture in vitro experiment (Borhani
et al., 2011). The study showed that after an initial deadlock,
F. velutipes was able to completely replace Ophiostoma ulmi
by F. velutipes. F. velutipes also partially replaced the other
three plant pathogenic fungi tested namely Fusarium oxysporum,
Pestalotiopsis funerea and Fusarium culmurum LM2091 (Borhani
et al., 2011). Recently, a study demonstrated that the extract from
F. velutipes exhibited inhibitory activity toward the adhesion of
pathogenic fungi (Sporothrix schenckii and Candida albicans) to
epithelial cells (L929 cell line) (Kashina et al., 2016).
Enokipodins are a group of α-cuparene type sesquiterpenoids
that have been isolated from F. velutipes and are known to
be major constituents responsible for F. velutipes antimicrobial
activities. Four enokipodins A (35), B (22), C (36) and D
(23) with known chemical structures have been isolated and
purified from the mycelial culture of F. velutipes by a group
of researchers (Ishikawa et al., 2000, 2001). This group of
compounds, enokipodins A–D (22, 23, 35, 36) were also
successfully synthesized chemically (Srikrishna and Rao, 2004;
Saito and Kuwahara, 2005; Secci et al., 2007). It was reported
that enokipodins A-D (22, 23, 35, 36) exhibited antibacterial
activity mainly against the Gram-positive bacteria such as B.
subtilis and S. aureus (Ishikawa et al., 2001, 2005; Saito and
Kuwahara, 2005). Moreover, both enokipodins A (35) and C
(36) demonstrated minimum inhibitory doses against B. subtilis
LMA0011 comparable to those of penicillin G (Ishikawa et al.,
2005). A more recent study investigated the effect of culture
conditions on the production and antimicrobial activity of the
antimicrobial metabolites of F. velutipes (De Melo et al., 2009).
The study revealed that dextrose potato broth best supported
mycelia growth while complete Pontecorvo’s culture medium
resulted in greater antimicrobial metabolite production by F.
velutipes (De Melo et al., 2009).
In addition to the discovery of enokipodins A–D (22, 23, 35,
36), another research group from China isolated new cuparene-
type sesquiterpenes from the solid culture of F. velutipes
which also demonstrated antibacterial activities (Wang et al.,
2012b). The chemical structures of these sesquiterpenes were
elucidated and named as flamvelutpenoids A–D (37 to 40). They
were shown to exhibit antibacterial activity against E. coli, B.
subtilis and methicillin-resistant S. aureus with MIC measuring
more than 100 µM (Wang et al., 2012b). Furthermore, Wang
et al. (2012d) also revealed the isolation of six new cuparene
sesquiterpenes, enokipodins E–J (25 to 30)with antibacterial and
antifungal activities. Enokipodins I (29) and J (30) were shown
to exhibit antibacterial activity against B. subtilis with MICs
of 164.3 ± 6.2 and 151.2 ± 4.5 µM, respectively. Meanwhile,
enokipodins F, G and I (26, 27, 29) exhibited antifungal activity
against Aspergillus fumigatus with MICs ranging between 229.1
and 235.1µM. Interestingly, the antifungal potency of F. velutipes
was found to be enhanced in selenium (Se)-enhanced cultivation
medium (Milovanovic et al., 2015). The antifungal activity of the
ethanol extract of F. velutipes mycelia supplemented with Se was
shown to be enhanced, as evidenced by 8-fold lower MIC against
Candida parapsilosis (Milovanovic et al., 2015).
Although numerous studies have demonstrated the
antimicrobial potential of F. velutipes as well as the bioactive
compounds responsible for the ascribed activity, additional work
to understand their mechanisms of action would need to be
undertaken before proceeding to practical implementation of
any of these compounds as nutraceuticals or drugs in the food
and pharmaceutical industries.
Anti-Inflammatory
Inflammation is known to be a complex biological response to
infection and tissue injury that ultimately leads to recovery of
tissue structure and function. However, prolonged inflammation
contributes to the development of many inflammatory diseases
(Supriady et al., 2015). Althoughmany steroidal and nonsteroidal
anti-inflammatory drugs have been introduced for anti-
inflammatory therapy, their prolonged use has been reported to
pose serious adverse effects including significant gastrointestinal
upset, gastritis, renal problems, and even myocardial infarction
and strokes (Hyllested et al., 2002; Basu and Hazra, 2006).
Therefore, much interest has been shown toward alternative
anti-inflammmatory agents of plant origin as they appear to be
natural and safe drugs which pose minimal, if any, adverse effects
(Supriady et al., 2015). A well-known medicinal mushroom,
F. velutipes has been shown to possess anti-inflammatory
activities. Gunawardena et al. (2014) revealed that unprocessed
F. velutipes mushrooms possess anti-inflammatory properties,
inhibiting the production of NO (IC50 = 0.024 ± 0.01 mg/mL)
and TNF-α (IC50 = 0.099 ± 0.012 mg/mL) from murine
macrophage RAW264.7 activated by lipopolysaccharides and
IFN-γ. Additionally, the study showed that mushrooms that had
undergone food processing steps such as boiling and heating
showed less potent anti-inflammatory property, suggesting that
the anti-inflammatory bioactive factors may have been degraded
in the processed mushroom. Another study showed that the
water and ethanol extracts of F. velutipes exhibited strong nitric
oxide inhibitory activity and also inhibitory effect on iNOS and
COX-2 expression in macrophages (Kang, 2012).
Hepatoprotective Activity
Recently, a considerable number of studies have focused on the
characterization of polysaccharides of mushrooms due to their
protective action against hepatotoxicity (Wu et al., 2011; Gan
et al., 2012; Soares et al., 2013; Liu et al., 2014). F. velutipes is
among the mushrooms documented to have potential in exerting
protective effect toward hepatocytes. Pang et al. (2007), isolated
an α-(1→4)-d-glucan, a water soluble polysaccharide (FVP2)
with hepatoprotective activitiy from F. velutipes. The study
indicated that FVP2 enhanced the growth of primary hepatocytes
from mice in vitro significantly at concentrations ranging
from 25 to 200 µg/mL. Pang et al. (2007) demonstrated the
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hepatoprotective effect of FVP2 was mediated by the inhibition
of the release of intracellular alanine aminotransferase (ALT)
from the intoxicated hepatocytes induced by carbon tetrachloride
(CCl4). The authors also suggested that FVP2may have protected
the hepatocytes by preventing the production of CCl3• radical
caused by CCl4, subsequently inhibiting lipid peroxidation and
intracellular release of ALT (Pang et al., 2007).
LIMITATIONS AND FUTURE WORKS
The collective evidence presented in this review strongly
suggests that F. velutipes should be exploited as a great
source for development of functional foods, nutraceuticals and
even pharmaceutical drugs. Despite that, there are still many
challenges that need to be faced in order to facilitate the
development of these natural products before they enter the
pharmaceutical markets (Wasser, 2011). One of them is that
considerable effort is required to perform precise identification
of specific bioactive molecules responsible for the bioactivity of
the mushroom extracts. This provides a better understanding
of the mechanism of action of each particular compound on
the ascribed bioactivity. Furthermore, this also would address
the issue of whether the bioactive effects are caused by a single
component or are the result of a synergistic effect from several
components in the extracts.
There is also insufficient quality control and regulatory
protocols to guarantee a standardized extraction process
and the eventual quality and efficacy of mushroom-derived
natural products. For instance, some compounds such as
polysaccharides, are highly diversified in structure and molecular
weight (Jing et al., 2014); hence, it is challenging to maintain
batch to batch quality. Without consistency in the quality of
the mushroom-derived natural products, the composition and
the effectiveness of any commercially available preparation of
mushroom products would be highly variable and different.
Hence, only proper standards and protocols can ensure the
product quality. Moreover, it is also important to establish simple
and reliable analytic techniques to assess the authenticity or
detect adulteration in mushrooms; preventing adverse effects
attributed to adulteration. Apart from the use of gene markers
to authenticate F. velutipes (Su et al., 2008; Zhang et al., 2010),
a recent effort has shown that the analysis of IR spectroscopic
fingerprints using principal component analysis is a reliable
identification and qualification technique suitable for quality
control of the polysaccharides extracted from F. velutipes (Jing
et al., 2014).
Even with the current knowledge on F. velutipes, there is still
limited work assessing the bioavailability, pharmacokinetics and
pharmacodynamics of the bioactive compounds isolated from F.
velutipes. A full understanding of the pharmacokinetic profiles
of the natural products from these mushrooms is required
as it impacts their bioactivity after metabolism. For instance,
information regarding the ability of a bioactive compound to be
absorbed from the site of administration and to pass through
several biological barriers are crucial for the compound to exert
its effect at the target site (Chen et al., 2011). To date, there
have been abundant scientific investigations involving extracts
or compounds of this mushroom and their potential health
promoting benefits toward mankind, mainly on the basis of in
vitro and in vivo animal trials. However, clinical studies exploring
the therapeutic potential of F. velutipes are unfortunately very few
in number. Therefore, clinical trials are highly needed to ascertain
the dosage, efficacy and safety of these compounds as adequate
alternatives to currently available drugs.
CONCLUSION
An increasing awareness of the potential side effects of
synthetic therapeutic agents and nutraceuticals has led to
increased efforts to seek out natural products with beneficial
effects on health. Studies have shown that F. velutipes, an
easily available mushroom, has excellent nutritional value
and also remarkable potential applications for medicinal
purposes. Nutritionally, F. velutipes is a good source for
carbohydrates, proteins, unsaturated fatty acids, many valuable
micronutrients and dietary fiber which are highly comparable
to vegetables. Although the nutritional values and culinary
uses of F. velutipes are well documented, its medicinal qualities
have yet to be. Bioactive polysaccharides extracted from F.
velutipes have been demonstrated to possess a wide variety
of bioactivities, particularly anticancer, immunomodulatory
and anti-neurodegenerative effects. However, the exact mode
of action of these carbohydrates is still elusive and deserves
special attention in future study. Extensive research has also
focused on a fungal immunomodulatory protein, FIP-fve
isolated from F. velutipes, which exhibits both promising
anticancer and immunomodulatory effects. The majority of the
studies showed congruent findings that the FIP-fve elicits its
immunomodulatory effects by shifting toward Th1 immune
response. Apart from that, extracts of F. velutipes are also found
to possess anticancer, anti-atherosclerotic, anti-thrombotic,
cholesterol lowering, anti-hypertensive, memory and learning
enhancement, antioxidant, antiaging, immunomodulatory,
melanosis inhibition, anti-inflammatory, anti-complement,
antimicrobial and hepatoprotective activities. A number of
chemically defined bioactive molecules from diverse chemical
groups have also been isolated from F. velutipes extracts that
show invaluable prospects for future applications in the form of
nutraceuticals/dietary supplements. In conclusion, F. velutipes
has great potential as a nutraceutical and functional food, as
well as potentially representing a valuable source for bioactive
compounds therapeutic use and pharmaceutical application.
The information presented in this review may also form the
basis of providing adequate knowledge for future studies
and developments as well as commercial exploitation of this
fascinating mushroom.
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